def14a
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the Securities
Exchange Act of 1934 (Amendment No. )
Filed by the Registrant þ
Filed by a Party other than the Registrant o
Check the appropriate box:
o |
|
Preliminary Proxy Statement |
o |
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
þ |
|
Definitive Proxy Statement |
o |
|
Definitive Additional Materials |
o |
|
Soliciting Material Pursuant to §240.14a-12 |
HCC Insurance Holdings, Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
þ |
|
No fee required. |
o |
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. |
|
(1) |
|
Title of each class of securities to which transaction applies: |
|
|
|
|
|
|
|
|
|
|
|
(2) |
|
Aggregate number of securities to which transaction applies: |
|
|
|
|
|
|
|
|
|
|
|
(3) |
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act
Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was
determined): |
|
|
|
|
|
|
|
|
|
|
|
(4) |
|
Proposed maximum aggregate value of transaction: |
|
|
|
|
|
|
|
|
|
|
|
(5) |
|
Total fee paid: |
|
|
|
|
|
|
|
|
|
o |
|
Fee paid previously with preliminary materials. |
|
o |
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2)
and identify the filing for which the offsetting fee was paid previously. Identify the
previous filing by registration statement number, or the Form or Schedule and the date of its
filing. |
|
(1) |
|
Amount Previously Paid: |
|
|
|
|
|
|
|
|
|
|
|
(2) |
|
Form, Schedule or Registration Statement No.: |
|
|
|
|
|
|
|
|
|
|
|
(3) |
|
Filing Party: |
|
|
|
|
|
|
|
|
|
|
|
(4) |
|
Date Filed: |
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
HCC
INSURANCE HOLDINGS, INC.
13403 Northwest Freeway
Houston, Texas
77040-6094
NOTICE OF ANNUAL MEETING OF SHAREHOLDERS
To Be Held May 21, 2009,
at 9:00 a.m. Houston time
NOTICE IS HEREBY GIVEN that the Annual Meeting of Shareholders
of HCC Insurance Holdings, Inc. will be held on Thursday,
May 21, 2009, at 9:00 a.m. Houston time, at the
Omni Hotel, Four Riverway, Houston, TX 77056 for the
following purposes:
1. To elect ten directors for a one-year term, each to
serve until the Annual Meeting of Shareholders in 2010 and until
his successor is duly elected and qualified.
2. To ratify the appointment of PricewaterhouseCoopers LLP
as auditors for 2009.
3. To transact such other business as may properly come
before the meeting and any postponement or adjournment thereof.
Our Board of Directors has fixed the close of business on
April 2, 2009 as the record date for determining those
shareholders who are entitled to notice of, and to vote at, the
Annual Meeting of Shareholders. A list of such shareholders will
be open to examination by any shareholder at the annual meeting
and for a period of ten days prior to the date of the annual
meeting during ordinary business hours at 13403 Northwest
Freeway, Houston, Texas. A copy of the Annual Report of HCC
Insurance Holdings, Inc. for the year ended December 31,
2008 is enclosed.
By Order of the Board of Directors,
James L. Simmons,
Vice President and Secretary
Houston, Texas
April 13, 2009
YOUR VOTE IS IMPORTANT. WHETHER OR NOT YOU INTEND TO BE
PRESENT AT THE MEETING, PLEASE MARK, SIGN AND DATE THE ENCLOSED
PROXY AND RETURN IT IN THE ENCLOSED PREPAID ENVELOPE OR, IF YOU
PREFER, SUBMIT YOUR PROXY BY TELEPHONE OR USING THE INTERNET, TO
ASSURE THAT YOUR SHARES ARE REPRESENTED AT THE MEETING. IF
YOU ATTEND THE MEETING, YOU MAY VOTE IN PERSON IF YOU WISH TO DO
SO, EVEN IF YOU HAVE PREVIOUSLY SUBMITTED YOUR PROXY.
HCC
INSURANCE HOLDINGS, INC.
13403 Northwest Freeway
Houston, Texas
77040-6094
PROXY
STATEMENT
ANNUAL
MEETING OF SHAREHOLDERS
May 21, 2009
INFORMATION
CONCERNING SOLICITATION AND VOTING
This Proxy Statement is first being mailed on or about
April 13, 2009 to shareholders of HCC Insurance Holdings,
Inc., which is sometimes referred to in this Proxy Statement as
HCC, or as we, us, or
our, in connection with the solicitation by our
Board of Directors of proxies to be voted at the Annual Meeting
of Shareholders to be held on Thursday, May 21, 2009, at
9:00 a.m. Houston time, at the Omni Hotel, Four
Riverway, Houston, TX 77056, and any postponement or adjournment
thereof. A shareholder giving a proxy has the power to revoke
the proxy at any time until 11:59PM Eastern time May 20,
2009. Such right of revocation is not limited by or subject to
compliance with any formal procedure.
This solicitation is made by HCC, and the cost of soliciting
proxies will be borne by HCC. Copies of solicitation material
may be furnished to brokers, custodians, nominees and other
fiduciaries for forwarding to beneficial owners of shares of our
common stock, and normal handling charges may be paid for such
forwarding service. Solicitation of proxies may be made by mail,
personal interview, telephone and facsimile by our officers and
other management employees, who will receive no additional
compensation for their services. We have retained Georgeson
Shareholder Communications, Inc., 199 Water Street,
26th Floor, New York, NY 10038, at an anticipated cost of
$7,000 plus reimbursement of
out-of-pocket
expenses, to provide services in connection with our annual
meeting, including the solicitation of proxies.
Only shareholders of record on our record date of April 2,
2009 will be entitled to vote at the annual meeting, and each
share will have one vote. At the close of business on such
record date, there were 112,070,307 shares of our common
stock outstanding and entitled to vote at the annual meeting.
Quorum and voting requirements are set forth in the Delaware
General Corporation Law and our governing documents. A majority
of the outstanding shares of our common stock, represented in
person or by proxy, will constitute a quorum at our annual
meeting. Abstentions, withhold votes and broker non-votes
(described below) are each included in the determination of the
number of shares present for purposes of determining the
presence of a quorum. The election of directors will be
determined by a plurality of the votes cast, which means that
the 10 nominees who receive the highest votes will be elected.
Withhold votes will not impact the outcome of the election of
directors. The affirmative vote of the holders of a majority of
the shares of our common stock present in person or represented
by proxy at the annual meeting and entitled to vote on the
matter is required for the ratification of our independent
registered public accounting firm. Abstentions have the effect
of an against vote. If you hold your shares in street
name through a broker or other nominee, your broker or
nominee may not be permitted to exercise voting discretion on
some of the items to be acted upon. Thus, if you do not give
your broker or nominee specific instructions, your shares may
not be voted on those items (broker non-votes) and will not be
counted in determining the number of shares necessary for
approval for each item. Our Board of Directors does not
anticipate calling for a vote on any matter other than those
described herein.
If you return your signed proxy card but do not mark the
boxes indicating how you wish to vote, your shares will be voted
FOR the election of the 10 director nominees named herein
and FOR ratification of the appointment of
PricewaterhouseCoopers LLP.
STOCK
OWNERSHIP OF MANAGEMENT
The following table sets forth certain information regarding the
beneficial ownership of our common stock as of the record date
by (a) each of our current and former executive officers
named in the Summary Compensation Table whom we refer to as
Named Executive Officers, (b) each of our
directors and (c) all of our directors and Named Executive
Officers as a group. Based on a review of Schedules 13D and 13G
filed with the SEC, there are no greater than 5% holders.
|
|
|
|
|
|
|
|
|
|
|
Amount and Nature
|
|
|
|
|
|
|
of Beneficial
|
|
|
Percent of Common
|
|
Name and Address of Beneficial Owner(1)
|
|
Ownership(2)
|
|
|
Stock Outstanding
|
|
|
Frank J. Bramanti
|
|
|
559,084
|
(3)
|
|
|
*
|
|
Patrick B. Collins
|
|
|
59,580
|
(4)
|
|
|
*
|
|
J. Robert Dickerson
|
|
|
95,330
|
(5)
|
|
|
*
|
|
Walter M. Duer
|
|
|
67,086
|
(6)
|
|
|
*
|
|
Edward H. Ellis, Jr.
|
|
|
213,708
|
(7)
|
|
|
*
|
|
James C. Flagg, Ph.D.
|
|
|
37,080
|
(8)
|
|
|
*
|
|
Allan W. Fulkerson
|
|
|
78,655
|
(9)
|
|
|
*
|
|
Thomas M. Hamilton
|
|
|
4,000
|
(10)
|
|
|
*
|
|
Craig J. Kelbel
|
|
|
188,500
|
(11)
|
|
|
*
|
|
John N. Molbeck, Jr.
|
|
|
401,279
|
(12)
|
|
|
*
|
|
Cory L. Moulton
|
|
|
95,957
|
(13)
|
|
|
*
|
|
James E. Oesterreicher
|
|
|
6,674
|
|
|
|
*
|
|
Michael A. F. Roberts
|
|
|
49,080
|
(14)
|
|
|
*
|
|
Robert A. Rosholt
|
|
|
2,427
|
|
|
|
*
|
|
Christopher J. B. Williams
|
|
|
5,830
|
|
|
|
*
|
|
Scott W. Wise
|
|
|
3,330
|
|
|
|
*
|
|
All Directors and Named Executive Officers as a group
(16 persons)
|
|
|
1,867,600
|
(15)
|
|
|
1.65
|
%
|
|
|
|
* |
|
Less than 1%. |
|
(1) |
|
The address for the listed beneficial owners is 13403 Northwest
Freeway, Houston, TX
77040-6094. |
|
(2) |
|
Directors and executive officers have sole voting and investment
powers of the shares shown unless otherwise indicated. |
|
(3) |
|
Includes 231,250 shares that Mr. Bramanti has the
right to acquire upon the exercise of options within
60 days from our record date. Includes 1,125 shares
owned of record by Mr. Bramantis wife in trust for
their children and 2,468 shares owned of record by their
children. Mr. Bramanti disclaims beneficial ownership of
these 3,593 shares. |
|
(4) |
|
Includes 31,250 shares that Mr. Collins has the right
to acquire upon the exercise of options within 60 days from
our record date. |
|
(5) |
|
Includes 31,250 shares that Mr. Dickerson has the
right to acquire upon the exercise of options within
60 days from our record date. |
|
(6) |
|
Includes 59,250 shares that Mr. Duer has the right to
acquire upon the exercise of options within 60 days from
our record date. Includes 2,006.5 shares owned of record by
a family limited partnership. |
|
(7) |
|
Includes 158,333 shares that Mr. Ellis has the right
to acquire upon the exercise of options within 60 days from
our record date. Includes 375 shares owned of record by
Mr. Ellis wife; Mr. Ellis disclaims beneficial
ownership of these shares. |
|
(8) |
|
Includes 31,250 shares that Dr. Flagg has the right to
acquire upon the exercise of options within 60 days from
our record date. |
2
|
|
|
(9) |
|
Includes 31,250 shares that Mr. Fulkerson has the
right to acquire upon the exercise of options within
60 days from our record date. Includes 7,500 shares
owned of record in Mr. Fulkersons IRA. The
39,905 shares Mr. Fulkerson directly owns are held in
a collateral custody account and pledged to secure a loan. |
|
(10) |
|
This total does not include 1998.24 shares of common stock
Mr. Hamilton has elected to defer under the HCC Insurance
Holdings, Inc. Nonqualified Deferred Compensation Plan for
Non-Employee Directors. Although Mr. Hamilton does not
currently beneficially own the shares, he has the contractual
right to receive them upon his separation from service with HCC. |
|
(11) |
|
Includes 185,000 shares that Mr. Kelbel has the right
to acquire upon the exercise of options within 60 days from
our record date. |
|
(12) |
|
Includes 317,500 shares that Mr. Molbeck has the right
to acquire upon the exercise of options within 60 days from
our record date. |
|
(13) |
|
Includes 72,500 shares that Mr. Moulton has the right
to acquire upon the exercise of options within 60 days from
our record date. |
|
(14) |
|
Includes 31,250 shares that Mr. Roberts has the right
to acquire upon the exercise of options within 60 days from
our record date. |
|
(15) |
|
Includes 1,180,083 shares that all Directors and Named
Executive Officers as a group have the right to acquire upon the
exercise of options within 60 days from our record date. |
3
PROPOSAL NUMBER
1 ELECTION OF DIRECTORS
Each director elected at our annual meeting will continue to
serve until his successor is duly elected and qualified at the
next annual meeting of shareholders in 2010 or until his earlier
death, resignation or removal. Each of the nominees is currently
a director of HCC. Our Board of Directors has determined that
each of Messrs. Duer, Flagg, Hamilton, Oesterreicher,
Rosholt, Williams and Wise are independent
directors, as that term is defined by the New York Stock
Exchange (NYSE). Such directors are collectively referenced in
this Proxy Statement as the Independent Directors.
Our management notes that each of the proposed nominees is
standing for re-election to our Board of Directors and that each
has served our shareholders interests well during his
tenure as a director. Our management believes that HCC and its
shareholders benefit from the wide variety of industry and
professional experience that characterizes the Independent
Director members of our Board of Directors.
The following table presents information concerning persons
nominated for election as directors of HCC, including current
membership on committees of our Board of Directors, principal
occupation or affiliations during the last five years, and
certain directorships held. Although our Board of Directors does
not contemplate that any of the nominees will be unable to
serve, if such a situation arises prior to the annual meeting,
the Board may reduce the size of the Board accordingly, or the
persons named in the enclosed form of Proxy will vote in
accordance with their best judgment for any substitute nominee.
Information
Regarding Nominees for Director
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Served as
|
|
|
|
|
|
|
Director
|
Name
|
|
Principal Occupation During the Past Five Years
|
|
Age
|
|
Since
|
|
Frank J. Bramanti
|
|
Mr. Bramanti is a director and, since November 2006, has served
as Chief Executive Officer of HCC. Mr. Bramanti has over
20 years experience in the insurance industry. Prior to his
becoming CEO, Mr. Bramanti had been retired from his position as
an Executive Vice President of HCC since the end of 2001. From
1980 until his retirement, he served HCC in various capacities,
including director, Secretary, Chief Financial Officer and
interim President. Mr. Bramanti is a member of our Investment
and Finance Committee and also serves as a director and officer
of several of our subsidiaries.
|
|
|
52
|
|
|
|
1997
|
|
|
|
|
|
|
|
|
|
|
|
|
Walter M. Duer
|
|
Mr. Duer is a Certified Public Accountant and a retired partner
in the international accounting firm KPMG LLP, where he was
employed from 1968 through 2004. Mr. Duer is a member of our
Audit and our Investment and Finance Committees.
|
|
|
62
|
|
|
|
2004
|
|
|
|
|
|
|
|
|
|
|
|
|
Edward H. Ellis, Jr.
|
|
Mr. Ellis is a director and an Executive Vice President and the
Chief Financial Officer of HCC. Mr. Ellis is a Certified Public
Accountant with over 32 years of public accounting
experience. Prior to joining us in 1997, Mr. Ellis served as a
partner specializing in the insurance industry in the
international accounting firm PricewaterhouseCoopers LLP from
1988 to 1997. Mr. Ellis is a member of our Investment and
Finance Committee and also serves as a director and officer of
several of our subsidiaries.
|
|
|
66
|
|
|
|
2001
|
|
|
|
|
|
|
|
|
|
|
|
|
James C. Flagg, Ph. D.
|
|
Dr. Flagg is a Certified Public Accountant and an Associate
Professor in the Department of Accounting in the Mays Business
School at Texas A&M University, where he has taught since
1988. Dr. Flagg holds a Master of Science in Economics, an
M.B.A. and a Ph.D. in Accounting. Dr. Flagg is Chairman of
our Audit Committee and a member of our Nominating and Corporate
Governance Committee. He is a member of the board of the Texas
State Board of Public Accountancy.
|
|
|
57
|
|
|
|
2001
|
|
4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Served as
|
|
|
|
|
|
|
Director
|
Name
|
|
Principal Occupation During the Past Five Years
|
|
Age
|
|
Since
|
|
Thomas M. Hamilton
|
|
Mr. Hamilton has been Co-owner of Medora Investments, a private
investment firm, since 2003. He served as the Chairman,
President and Chief Executive Officer of EEX Corporation from
1997 until his retirement in 2002. Previously, Mr. Hamilton held
various executive positions at other oil and gas companies,
including Pennzoil, BP and Exxon. Mr. Hamilton serves on our
Compensation Committee and is the Chairman of our Nominating and
Corporate Governance Committee. Mr. Hamilton is a director
of FMC Technologies, Inc. (NYSE symbol: FTI), Hercules Offshore,
Inc. (Nasdaq symbol: HERO) and Methanex Corporation (Nasdaq
global market symbol: MEOH). Mr. Hamilton was identified as a
potential candidate for our Board by Korn/Ferry International.
|
|
|
65
|
|
|
|
2008
|
|
|
|
|
|
|
|
|
|
|
|
|
John N. Molbeck, Jr.
|
|
Mr. Molbeck is a director and, since 2006, has served as
President and Chief Operating Officer of HCC, a position he
previously held from 1997 to 2002. From 2003 through 2005, Mr.
Molbeck served as Chief Executive Officer of Jardine Lloyd
Thompson LLC, a retail insurance brokerage firm, which was, at
the time, a subsidiary of Jardine Lloyd Thompson Group, plc
(London Stock Exchange code: JLT). Prior to initially joining
HCC in 1997, Mr. Molbeck had been the Managing Director of Aon
Natural Resources Group, a subsidiary of Aon Corporation (NYSE
symbol: AOC). Mr. Molbeck is a member of our Investment and
Finance Committee and an ex officio member of our Enterprise
Risk Oversight Committee. He also serves as a director and
officer of several of our subsidiaries.
|
|
|
62
|
|
|
|
2005
|
|
|
|
|
|
|
|
|
|
|
|
|
James E. Oesterreicher
|
|
Mr. Oesterreicher is the Retired Chairman of the Board of J.C.
Penney Company, Inc. He served as Chairman of the Board and
Chief Executive Officer from 1997 until 2000 and as Vice
Chairman and Chief Executive Officer from 1995 to 1997. Mr.
Oesterreicher is Chairman of our Compensation Committee and a
member of our Nominating and Corporate Governance Committee. In
2008, he also served on our Special Litigation Committee, which
completed its work and disbanded in April 2008, in connection
with certain derivative litigation. Mr. Oesterreicher also
serves as a director of Brinker International, Inc. (NYSE
symbol: EAT) and on the boards of Texas Health Resources, Circle
Ten Council Boy Scouts of America, National March of
Dimes Advisory Board and Spina Bifida Birth Defects Foundation.
|
|
|
67
|
|
|
|
2007
|
|
5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Served as
|
|
|
|
|
|
|
Director
|
Name
|
|
Principal Occupation During the Past Five Years
|
|
Age
|
|
Since
|
|
Robert A. Rosholt
|
|
Mr. Rosholt is the former Chief Financial Officer for Nationwide
Mutual Insurance Company from 2002 to 2008. Prior to joining
Nationwide, Mr. Rosholt served as Executive Vice President and
Chief of Operations at the risk services unit of Aon
Corporation, a leading global provider of risk management
services, insurance and reinsurance brokerage and human capital
consulting, from 2000 to 2002. Mr. Rosholt also served as Chief
Financial Officer at First Chicago Corporation and its successor
companies including Bank One, from 1974 to 2000, where he had
oversight for capital and asset liability management as well as
proprietary investment activities. Mr. Rosholt is a member of
our Audit Committee and is Chairman of our Enterprise Risk
Oversight Committee. Mr. Rosholt is a director of Abercrombie
& Fitch Co. (NYSE symbol: ANF) and a member of the advisory
board of the Financial Institution Advisory Services of Alrarez
and Marsal. Mr. Rosholt was identified as a potential
candidate for our Board by Korn/Ferry International.
|
|
|
59
|
|
|
|
2008
|
|
|
|
|
|
|
|
|
|
|
|
|
Christopher J. B. Williams
|
|
Mr. Williams is currently Chairman of Wattle Creek Winery, a
position he has held since retiring as National Director for
Life, Accident & Health of Willis Re in 2005. He has over
30 years of insurance industry experience. Mr. Williams is
the Chairman of our Board of Directors, a position he assumed in
August 2008. Mr. Williams is a member of our Enterprise Risk
Oversight and our Compensation Committees. He also serves as an
ex officio member of our Audit, our Nominating and Corporate
Governance and our Investment and Finance Committees. In 2008,
Mr. Williams served on our Special Litigation Committee, which
completed its work and disbanded in April 2008, in connection
with certain derivative litigation.
|
|
|
53
|
|
|
|
2007
|
|
|
|
|
|
|
|
|
|
|
|
|
Scott W. Wise
|
|
Mr. Wise is currently the Chief Investment Officer for Rice
University, a position he has held since 1989. Mr. Wise is
responsible for all endowment matters for Rice University,
including asset allocation, selection and management of
investment managers, investment performance and endowment
spending. Mr. Wise is also responsible for developing and
overseeing Rice Universitys debt financing program. Mr.
Wise is Chairman of our Investment and Finance Committee and is
a member of our Enterprise Risk Oversight Committee.
|
|
|
59
|
|
|
|
2008
|
|
Our Board
of Directors recommends that our shareholders vote
FOR each of the proposed nominees.
Information
Regarding Executive Officers Who Are Not Nominees for
Director
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Served the
|
|
|
|
|
|
|
Company
|
Name
|
|
Principal Occupation During the Past Five Years
|
|
Age
|
|
Since
|
|
Barry J. Cook
|
|
Mr. Cook is an Executive Vice President of HCC and is the Chief
Executive Officer of HCC Insurance Holdings (International)
Limited. Mr. Cook oversees our international operations. From
1992 to 2005, Mr. Cook served as Chief Executive Officer of
Rattner Mackenzie Limited, which we acquired in 1999. Mr. Cook
also serves as a director and officer of several of our
subsidiaries.
|
|
|
48
|
|
|
|
1999
|
|
6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Served the
|
|
|
|
|
|
|
Company
|
Name
|
|
Principal Occupation During the Past Five Years
|
|
Age
|
|
Since
|
|
Craig J. Kelbel
|
|
Mr. Kelbel is an Executive Vice President of HCC and is the
President and Chief Executive Officer of HCC Life Insurance
Company. Mr. Kelbel oversees our group life, accident and health
operations. Prior to joining us, Mr. Kelbel was the President of
USBenefits Insurance Services, Inc. and a Vice President of its
parent, The Centris Group, Inc., which was acquired by HCC in
1999. Mr. Kelbel has over 28 years of experience in the
insurance industry. Mr. Kelbel also serves as a director and
officer of several of our subsidiaries.
|
|
|
54
|
|
|
|
1999
|
|
|
|
|
|
|
|
|
|
|
|
|
Cory L. Moulton
|
|
Mr. Moulton is the Executive Vice President U.S
Property and Casualty Operations of HCC. Mr. Moulton oversees
our domestic property and casualty operations. Mr. Moulton has
served as the Chief Executive Officer of our subsidiary
Professional Indemnity Agency, Inc., from 2005 to the present.
He was previously the General Partner of Tobat Capital, LLC, a
venture capital firm that invested in early stage financial
services technology companies, from 2000 to 2005, and served in
various capacities with E. W. Blanche, an international
reinsurance intermediary, including President
International Operations, from 1992 to 2000. Mr. Moulton also
serves as a director and officer of several of our subsidiaries.
|
|
|
40
|
|
|
|
2005
|
|
|
|
|
|
|
|
|
|
|
|
|
Pamela J. Penny
|
|
Ms. Penny is Executive Vice President and Chief Accounting
Officer of HCC. She previously served as Senior Vice
President Finance from 2004 to November 2008. Prior
to joining us, Ms. Penny served as Senior Vice President and
Controller for Aegis Mortgage Corporation from 2003 to 2004 and
served in varying capacities with American International Group,
Inc. (formerly American General Corporation), including Senior
Vice President & Controller of American General, from 1991
to 2003. She was previously a partner in the international
accounting firm KPMG LLP. Ms. Penny is a Certified Public
Accountant and also serves as a director and officer of several
of our subsidiaries.
|
|
|
54
|
|
|
|
2004
|
|
|
|
|
|
|
|
|
|
|
|
|
Randy D. Rinicella
|
|
Mr. Rinicella is Senior Vice President and General Counsel of
HCC. Prior to joining us, Mr. Rinicella was the Vice President,
General Counsel and Secretary of Dresser Rand Group, Inc., a
publicly-traded equipment supplier to the worldwide oil, gas,
petrochemical and process industries, from 2005 until 2007.
Mr. Rinicella was a shareholder at the national law firm of
Buchanan Ingersoll PC from 2004 until 2005, where he was a
member of the firms corporate finance department, and from
2002 to 2004, he was a partner in the law firm of Roetzel &
Andress. Mr. Rinicella serves as a director and officer of
several of our subsidiaries.
|
|
|
51
|
|
|
|
2007
|
|
|
|
|
|
|
|
|
|
|
|
|
Michael J. Schell
|
|
Mr. Schell is Executive Vice President and Chief Underwriting
Officer of HCC, the Chief Executive Officer of Houston Casualty
Company and other of our insurance company subsidiaries, and
oversees our domestic surety and credit operations. Prior to
joining us in 2002, Mr. Schell was with the St. Paul Companies
for 25 years, most recently as President and Chief
Operating Officer of St. Paul Re. Mr. Schell also serves as a
director and officer of several of our subsidiaries.
|
|
|
58
|
|
|
|
2002
|
|
7
Executive
Sessions of the Board of Directors
Independent Directors meet regularly in executive session at
each regularly scheduled meeting of our Board of Directors.
Christopher J.B. Williams, as the independent Chairman of the
Board, serves as the presiding director at each executive
session. Our Independent Directors met in executive session four
times in 2008.
Communications
with Directors
Our Board of Directors has adopted corporate governance
guidelines that provide that our shareholders and other
interested parties may communicate with one or more of our
directors by mail in care of: James L. Simmons, Secretary, HCC
Insurance Holdings, Inc., 13403 Northwest Freeway, Houston,
Texas
77040-6094.
Such communications should specify the intended recipient or
recipients. All such communications, other than unsolicited
commercial solicitations, will be forwarded to the appropriate
director, or directors, for review.
Board
Attendance at the Annual Meeting
Our policy is to have our directors attend our annual meeting.
Last year, all of our then-serving directors attended the annual
meeting.
Code of
Business Conduct and Ethics
We have adopted a Code of Business Conduct and Ethics that is
applicable to all of our directors, officers and other
employees. The Code is posted under the Corporate Governance
portion of the Investor Relations section on our website at
www.hcc.com and is available to any shareholder upon
request.
Director
Independence
Our Board of Directors has established criteria for determining
director independence as set forth in our Corporate
Governance Guidelines. In particular, no director shall be
deemed to be independent unless the Board, as a
whole, shall have affirmatively determined that no material
relationship exists between such director and HCC other than the
directors service as a member of our Board of Directors.
In addition, the following criteria apply to determine
independence:
|
|
|
|
|
no director who is an employee, or whose immediate family member
is an executive officer of HCC, is deemed independent until
three years after the end of such employment relationship;
|
|
|
|
no director who receives, or whose immediate family member
receives, more than $120,000 in any twelve-month period in
direct compensation from HCC, other than director and committee
fees and pension or other forms of deferred compensation for
prior service (provided such compensation is not contingent in
any way on continued service), is deemed independent until three
years after he or she ceases to receive more than $120,000 in
any twelve-month period of such compensation;
|
|
|
|
no director is independent who (i) is a current partner or
employee of a firm that is HCCs internal or external
auditor; (ii) has an immediate family member who is a
current partner of such firm; (iii) has an immediate family
member who is a current employee of such firm and personally
works on the HCCs audit; or (iv) was or had an
immediate family member who was within the last three years a
partner or employee of such firm and personally worked on
HCCs audit within that time;
|
|
|
|
no director who is employed, or whose immediate family member is
employed, as an executive officer of another company where any
of our present executives serve on that companys
compensation committee is deemed independent until three years
after the end of such service or the employment relationship;
|
|
|
|
no director who is an executive officer or an employee, or whose
immediate family member is an executive officer, of a company
that makes payments to, or receives payments from, HCC for
property or services in an amount that, in any single fiscal
year, exceeds the greater of $1.0 million or 2% of such
other companys consolidated gross revenues, is deemed
independent until three years after falling below such threshold;
|
8
|
|
|
|
|
no director who has a personal services contract with HCC, or
any member of HCCs senior management is independent;
|
|
|
|
no director who is affiliated with a
not-for-profit
entity that receives significant contributions from HCC is
independent;
|
|
|
|
no director who is employed by a public company at which an
executive officer of HCC serves as a director is independent;
|
|
|
|
no director is independent who received, during calendar years
2004-2007,
remuneration, directly or indirectly, as a result of service as,
or compensation paid to an entity affiliated with the director
that serves as:
|
|
|
|
|
|
an advisor, consultant, or legal counsel to HCC or to a member
of HCCs senior management; or
|
|
|
|
a significant customer or supplier of HCC;
|
|
|
|
|
|
no director who, during calendar years
2004-2007,
had any business relationship with HCC for which HCC has been
required to make disclosure under Item 404(a) of Regulation
S-K (Transactions with Related Persons) is independent provided
that transactions disclosed in our 2007 proxy statement are
grandfathered into this requirement;
|
|
|
|
no director who had any relationship described in the first
bullet point above or in any of the sixth through the tenth
bullet points above with any affiliate of HCC is
independent; and
|
|
|
|
no director who is a member of the immediate family of any
person who fails to satisfy the independence requirements
described in the first bullet point above or in any of the sixth
through the eleventh bullet points above is independent.
|
In addition, members of our Audit Committee must meet the
following additional independence requirements:
|
|
|
|
|
no director who is a member of the Audit Committee shall be
deemed independent if such director is affiliated with HCC or
any of its subsidiaries in any capacity, other than in such
directors capacity as a member of our Board of Directors,
the Audit Committee or any other Board committee; and
|
|
|
|
no director who is a member of the Audit Committee shall be
deemed independent if such director receives, directly or
indirectly, any consulting, advisory or other compensatory fee
from HCC or any of its subsidiaries, other than fees received in
such directors capacity as a member of our Board of
Directors, the Audit Committee or any other Board committee, and
fixed amounts of compensation under a retirement plan (including
deferred compensation) for prior service with HCC (provided such
compensation is not contingent in any way on continued service).
|
In addition to the independence standards above, unless
otherwise prohibited by NYSE rules, the Board has determined
that any commercial or charitable relationship that is not
required to be reported in a proxy statement will not be
considered a material relationship that would impair a
directors independence.
Our Board of Directors has affirmatively determined that each of
Messrs. Duer, Flagg, Hamilton, Oesterreicher, Rosholt,
Williams and Wise meets the general criteria for independence
set forth above and that all members of the Audit Committee meet
the further requirements for independence set forth above.
Meetings
and Committees of the Board of Directors
During 2008, our Board of Directors met 11 times and acted by
written consent on various other occasions. Each person
nominated to be a director attended, or participated via
teleconference, in 75% or more of the meetings of the Board of
Directors and the meetings of any committee on which he served.
Our Board of Directors has standing Audit, Compensation,
Enterprise Risk Oversight, Investment and Finance, and
Nominating and Corporate Governance Committees, each of which
has a written charter. Copies of the Audit Committee,
Compensation Committee, and Nominating and Corporate Governance
Committee Charters, as well as our Corporate Governance
Guidelines, are available under the Corporate Governance portion
of the Investor Relations section of our website at
9
www.hcc.com. In addition, a printed copy of any of these
documents will be provided to any shareholder who
requests it.
Audit
Committee
Our Audit Committee consists of three Independent Directors. The
members of the Audit Committee are Walter M. Duer, James C.
Flagg (Chairman) and Robert A. Rosholt. In addition, Christopher
J.B. Williams serves as an ex officio member of the Audit
Committee. The Audit Committee met seven times in 2008.
The Audit Committees primary purpose is to assist our
Board of Directors oversight of (a) the integrity of
our consolidated financial statements and disclosures;
(b) our compliance with legal and regulatory requirements;
(c) our independent registered public accounting
firms qualifications, performance, independence and fees;
and (d) our internal audit function. The Audit Committee
has the sole authority to appoint and terminate our independent
registered public accounting firm. Our Board of Directors has
determined that each of Messrs. Duer, Flagg and Rosholt is
an audit committee financial expert as described in
Item 407(d)(5)(ii) of the SECs
Regulation S-K.
In addition, our Board of Directors has determined that each
member of the Audit Committee is independent, as independence
for audit committee members is defined in the listing standards
of the NYSE. The Audit Committee is established in accordance
with Section 3(a)(58)(A) of the Securities Exchange Act of
1934.
Compensation
Committee
Our Compensation Committee consists of three Independent
Directors. The members of the Compensation Committee are Thomas
H. Hamilton, James E. Oesterreicher (Chairman) and Christopher
J. B. Williams. The Compensation Committee met nine times in
2008.
The Compensation Committee has the responsibility for assuring
that our senior executives are compensated in a manner that is
consistent with the compensation philosophy and strategy of our
Board of Directors and that is in compliance with the
requirements of the regulatory bodies that oversee our
operations. Generally, the Compensation Committee is charged
with the authority to review and approve our compensation
philosophy and our executive compensation programs, levels,
plans and awards. The Compensation Committee also administers
our incentive plans and our stock-based compensation plans and
reviews and approves general employee benefit plans on an
as-needed basis. The Compensation Committee also has the
authority to retain, approve fees and other terms for, and
terminate any compensation consultant, outside counsel,
accountant or other advisor hired to assist the Compensation
Committee in the discharge of its responsibilities. The Chief
Executive Officer makes recommendations to the Compensation
Committee with respect to the form and amount of executive
compensation. In addition, under our Compensation Committee
Charter and under our 2008 Flexible Incentive Plan, the
Compensation Committee may delegate its authority under such
plans to management; however, under our currently existing
internal controls with respect to our stock option granting
practices, such authority may not be delegated with respect to
the granting of options. The Compensation Committee charter
allows delegation of Committee authority to subcommittees. See
the Compensation Discussion and Analysis below for
information on our process and procedures for determining 2008
executive officer compensation. Our Board of Directors has
determined that each member of the Compensation Committee is
independent, as independence for compensation committee members
is defined in the listing standards of the NYSE.
Compensation
Committee Interlocks and Insider Participation
No member of the Compensation Committee is or has been an
officer or employee of us or any of our subsidiaries. No
executive officer of ours served as a member of the Board of
Directors or compensation committee (or other Board committee
performing similar functions or, in the absence of any such
committee, the entire Board of Directors) of another
corporation, one of whose executive officers served on our
Compensation Committee or as our director. No executive officer
or director had a relationship with us requiring disclosure
under
Regulation S-K
Item 404.
10
Enterprise
Risk Oversight Committee
The Enterprise Risk Oversight Committee was established in
August 2008. Our Enterprise Risk Oversight Committee consists of
three independent directors. The members of the Enterprise Risk
Oversight Committee are Robert A. Rosholt (Chairman),
Christopher J.B. Williams and Scott W. Wise. In addition, John
N. Molbeck, Jr. serves as an ex officio member of the
Enterprise Risk Oversight Committee. The Enterprise Risk
Oversight Committee met one time in 2008.
The Enterprise Risk Oversight Committee is charged with
assisting the Board of Directors with oversight of
managements responsibility to identify, assess, prioritize
and manage all material risks to HCCs business objectives.
In this regard, the Enterprise Risk Oversight Committee reviews
managements assessment of risks and mitigation strategies
with respect to our business.
Investment
and Finance Committee
Our Investment and Finance Committee consists of five directors.
The members of the Investment and Finance Committee are Frank J.
Bramanti, Walter M. Duer, Edward H. Ellis, Jr., John N.
Molbeck, Jr. and Scott W. Wise (Chairman). In addition,
Christopher J.B. Williams serves as an ex officio member of the
Investment and Finance Committee. The Investment and Finance
Committee met seven times in 2008.
The Investment and Finance Committee is charged with
establishing investment policies for us and our subsidiaries and
directing the investment of our funds, and those of our
subsidiaries, in accordance with those policies. In this regard,
the Investment and Finance Committee oversees the investment
management activities of our third-party investment managers and
oversees our corporate financing activities.
Nominating
and Corporate Governance Committee
Our Nominating and Corporate Governance Committee consists of
three Independent Directors. The members of the Nominating and
Corporate Governance Committee are James C. Flagg, Thomas M.
Hamilton (Chairman) and James E. Oesterreicher. In addition,
Christopher J.B. Williams serves as an ex officio member of the
Nominating and Corporate Governance Committee. The Nominating
and Corporate Governance Committee met 10 times in 2008.
The Nominating and Corporate Governance Committee is charged
with identifying and making recommendations to our Board of
Directors of individuals suitable to become members of the Board
of Directors and overseeing the administration of our various
policies related to corporate governance matters. Our Board of
Directors has determined that each member of the Nominating and
Corporate Governance Committee is independent, as independence
for nominating committee members is defined in the listing
standards of the NYSE.
Director
Nominations
The Nominating and Corporate Governance Committee has
established certain criteria as guidelines in considering
nominations for the Board of Directors. The criteria include:
|
|
|
|
|
the candidates independence;
|
|
|
|
the candidates depth of business experience;
|
|
|
|
the candidates availability to serve;
|
|
|
|
the candidates integrity and personal and professional ethics;
|
|
|
|
the balance of the business experience on the Board as a
whole; and
|
|
|
|
the need for specific expertise on the Board.
|
These criteria are not exhaustive, and the Nominating and
Corporate Governance Committee and the Board of Directors may
consider other qualifications and attributes that they believe
are appropriate in evaluating the ability of an individual to
serve as a member of the Board of Directors. The Nominating and
Corporate Governance Committees goal is to assemble a
Board of Directors that brings to us a variety of perspectives
and skills derived
11
from high quality business and professional experience. In order
to ensure that the Board consists of members with a variety of
perspectives and skills, the Nominating and Corporate Governance
Committee has not set any minimum qualifications and also
considers candidates with appropriate non-business backgrounds.
Other than ensuring that at least one independent member of the
Board is a financial expert and a majority of the Board members
meet all applicable independence requirements, the Nominating
and Corporate Governance Committee does not have any specific
skills that it believes are necessary for any individual
director to possess. Instead, the Committee evaluates potential
nominees based on the contribution such nominees
background and skills could have upon the overall functioning of
the Board.
The Board of Directors believes that, based on the Nominating
and Corporate Governance Committees knowledge of our
Corporate Governance Principles and the needs and qualifications
of the Board at any given time, the Nominating and Corporate
Governance Committee is best equipped to select nominees that
will result in a well-qualified and well-rounded Board of
Directors. In making its nominations, the Nominating and
Corporate Governance Committee identifies nominees by first
evaluating the current members of the Board willing to continue
their service. Current members with qualifications and skills
that are consistent with the Nominating and Corporate Governance
Committees criteria for Board service are generally
re-nominated. When identifying new candidates to serve on our
Board, the Nominating and Corporate Governance Committee
undertakes a process that will entail the solicitation of
recommendations from any of our incumbent directors, our
management or our shareholders. Following a review of the
qualifications, experience and backgrounds of these candidates,
the Nominating and Corporate Governance Committee will make its
recommendation to the Board of Directors. In addition, the
committee has the authority under its charter to retain a search
firm for this purpose. In 2008, the committee retained
Korn/Ferry International to assist in identifying candidates to
serve on our Board.
Shareholder
Recommendations
The Charter of the Nominating and Corporate Governance Committee
provides that the committee will consider proposals for nominees
for director from shareholders. Shareholder nominations for
director should be made in writing to James L. Simmons,
Secretary, HCC Insurance Holdings, Inc., 13403 Northwest
Freeway, Houston, Texas
77040-6094.
The Nominating and Corporate Governance Committee will consider
candidates recommended by shareholders based on the criteria
described above. Although the Nominating and Corporate
Governance Committee will consider candidates to the Board, the
Board may determine not to nominate those candidates.
In order to recommend a director to be nominated at a meeting of
shareholders, we require that a shareholder follow the
procedures set forth in this section. In order to recommend a
nominee for a director position, a shareholder must be a
shareholder of record at the time such shareholder gives notice
of recommendation and must be entitled to vote for the election
of directors at the meeting at which such nominee will be
considered. Shareholder recommendations must be made pursuant to
written notice delivered to our Secretary at the principal
executive offices of HCC:
|
|
|
|
|
in the case of a nomination for election at an annual meeting,
not less than 45 nor more than 75 days prior to the first
anniversary of the date of our notice of annual meeting for the
preceding years annual meeting; and
|
|
|
|
in the case of a special meeting at which directors are to be
elected, not later than the close of business on the later of
the 90th day prior to such special meeting or the tenth day
following the day on which public announcement is first made of
the date of the meeting and of the nominees proposed by our
Board of Directors to be elected at the special meeting.
|
In the event that the date of the annual meeting is changed by
more than 30 days from the anniversary date of the
preceding years annual meeting, the shareholder notice
described above will be deemed timely if it is received not
later than the close of business on the later of the
90th day prior to such annual meeting or the tenth day
following the day on which public announcement of the date of
such meeting is first made.
The shareholder notice must set forth the following:
|
|
|
|
|
as to each person the shareholder proposes to nominate for
election as a director, all information relating to such person
that would be required to be disclosed in solicitations of
proxies for the election of such
|
12
|
|
|
|
|
nominees as directors pursuant to Regulation 14A under the
Exchange Act, and such persons written consent to serve as
a director if elected; and
|
|
|
|
|
|
as to the nominating shareholder and the beneficial owner, if
any, on whose behalf the nomination is made, such
shareholders and beneficial owners name and address
as they appear on our books, the class and number of shares of
our common stock that are owned beneficially and of record by
such shareholder and such beneficial owner, and an affirmative
statement of whether either such shareholder or such beneficial
owner intends to deliver a proxy statement and form of proxy to
a sufficient number of shareholders to elect such nominee or
nominees.
|
In addition to complying with the foregoing procedures, any
shareholder recommending a director candidate must also comply
with all applicable requirements of the Exchange Act, including
the rules and regulations under such Act.
Special
Litigation Committee
In May 2007, our Board of Directors formed a Special Litigation
Committee of independent, disinterested directors to undertake a
review of the derivative and class action litigation that arose
from our disclosures with regard to our past stock option
granting practices. The Special Litigation Committee was
composed of two independent, disinterested directors. The
members were James E. Oesterreicher and Christopher J.B.
Williams. The Special Litigation Committee did not hold any
meetings during 2008. The Special Litigation Committee completed
its duties and was disbanded on April 1, 2008.
Certain
Relationships and Related Transactions
We are not a party to any transaction with executive officers or
directors that is required to be disclosed under
Item 404(a) of
Regulation S-K.
There are no family relationships among the executive officers
and directors, and there are no arrangements or understandings
between any Independent Director or any other person pursuant to
which that Independent Director was selected as a director.
Board
Ratification of Related Transactions
Not less than annually, our Board of Directors undertakes the
review and approval of all related-party transactions. This
policy covers any transaction valued at greater than $120,000
between us or our subsidiaries and any of our executive
officers, directors, nominees for director, holders of greater
than five percent of our shares, and any of such parties
immediate family members. Under our policy, covered transactions
are to be reviewed by the disinterested members of our Board of
Directors, who shall satisfy themselves that (i) all
material facts with respect to the transaction have been
disclosed to the Board of Directors for its consideration and
(ii) that the transaction is fair to HCC. As a result of
this review, approval of a transaction may be denied if the
transaction is not fair to HCC or is otherwise a violation of
our Code of Business Conduct and Ethics. Our policy is in
writing and can be found in our Corporate Governance Guidelines.
Advances
of Defense Costs for Certain Litigation Matters
Certain members of our current Board of Directors and certain
current and former officers and directors were named as
defendants in lawsuits arising out of the issues related to our
past practices related to granting stock options. The current
and former directors and officers who were named as defendants
in these actions have a legal right under Delaware corporate
law, indemnification agreements with us and our bylaws to
advancement of their costs of defense. Accordingly, in 2008, we
advanced defense costs of approximately $0.2 million on
behalf of our
13
Named Executive Officers and directors. We recovered a
significant portion of these monies advanced from our
directors and officers liability insurance.
Section 16(a)
Beneficial Ownership Reporting Compliance
Section 16(a) of the Exchange Act requires our directors
and executive officers, as defined under the Exchange Act, and
persons who own more than 10% of a registered class of our
equity securities to file initial reports of ownership and
changes in ownership with the SEC. Such executive officers,
directors and shareholders are required by SEC regulations to
furnish us with copies of all Section 16(a) forms they
file. Mr. Hamiltons initial grant of 1,988 common
shares upon his joining our Board on November 20, 2008, the
receipt of which shares was deferred by Mr. Hamilton under
our Non-Employee Director Deferred Compensation Plan, was not
timely filed on Form 4, but such grant has been
subsequently reported on Form 4. Otherwise, based solely
upon a review of the copies of such forms furnished to us and
written representations from our directors and executive
officers, all persons subject to the reporting requirements of
Section 16(a) filed all required reports on a timely basis
in 2008.
14
EXECUTIVE
COMPENSATION
Compensation
Discussion and Analysis
This Compensation Discussion and Analysis explains the
philosophy underlying our compensation strategy and the
fundamental elements of compensation paid to our Chief Executive
Officer, Chief Financial Officer, and other individuals, whom we
refer to as Named Executive Officers or
executive officers, included in the Summary
Compensation Table for the 2008 calendar year. Specifically,
this Compensation Discussion and Analysis addresses the
following:
|
|
|
|
|
Objectives of our compensation programs;
|
|
|
|
What our compensation programs are designed to reward;
|
|
|
|
Elements of compensation provided to the Named Executive
Officers;
|
|
|
|
How we determine each element of compensation and why we pay
each element;
|
|
|
|
How we determine executive officer compensation; and
|
|
|
|
Other important compensation policies affecting the Named
Executive Officers.
|
Objectives
of Our Compensation Programs
Our business plan is shaped by our underlying business
philosophy, which is to maximize underwriting profit and net
earnings while preserving and achieving long-term growth of
shareholders equity. As a result, our primary objective is
to increase net earnings rather than market share or gross
written premium.
In our ongoing operations, we will continue to:
|
|
|
|
|
emphasize the underwriting of lines of business in which we
anticipate we will earn underwriting profits (based on various
factors, including premium rates, the availability and cost of
reinsurance, policy terms and conditions, and general market
conditions);
|
|
|
|
limit our insurance companies aggregate net loss exposure
from a catastrophic loss through
|
|
|
|
|
|
prudent, limited underwriting,
|
|
|
|
the use of reinsurance for those lines of business exposed to
such losses, and
|
|
|
|
diversification into lines of business not exposed to such
losses; and
|
|
|
|
|
|
consider the potential acquisition of specialty insurance
operations and other strategic investments.
|
With the goal of assisting in achieving the foregoing business
strategy, our Compensation Committee designs our compensation
programs to:
|
|
|
|
|
recruit and retain top executive officers who are experienced,
highly qualified individuals in a position to make significant
contributions to our success;
|
|
|
|
provide incentives to motivate executive officers to ensure
exceptional performance and desired financial results and to
reward such performance;
|
|
|
|
provide an opportunity for executives to develop a significant
ownership stake in our company; and
|
|
|
|
align the executive officers interests with the long-term
interests of our shareholders.
|
What
Our Compensation Programs Are Designed to Reward
Our compensation programs are designed to reward executive
officers who are capable of leading us in achieving our business
strategy on both a short-term and long-term basis. In addition,
we reward qualities that we believe help achieve our strategy
such as:
|
|
|
|
|
individual performance in light of general economic and
industry-specific conditions;
|
|
|
|
individual performance that supports our core values;
|
|
|
|
teamwork;
|
|
|
|
resourcefulness;
|
15
|
|
|
|
|
the ability to manage our business;
|
|
|
|
level of job responsibility; and
|
|
|
|
tenure with our company.
|
Elements
of Compensation Provided to the Named Executive
Officers
We have determined that our companys and our
shareholders interests are best served by entering into
multi-year employment agreements with the Named Executive
Officers. Such agreements are the result of arms length
negotiations between the Named Executive Officer and the
Compensation Committee. We believe that such multi-year
employment arrangements benefit us and our shareholders by
permitting us to attract and retain executive officers with
demonstrated leadership abilities and to secure the services of
such executive officers over an extended period of time. In
addition, multi-year employment agreements align executive
interests with the long-term interests of HCC and serve our
recruitment and retention goals by providing executive officers
with security based on the knowledge of how they will be
compensated over the term of the agreement. A summary of the
principal terms of these employment agreements is included below
under the caption Employment Agreements and Potential
Payments Upon Termination or Change of Control.
The elements of compensation we used during 2008 to compensate
the Named Executive Officers included:
|
|
|
|
|
Base salary;
|
|
|
|
Annual incentives;
|
|
|
|
Long-term equity awards;
|
|
|
|
Nonqualified deferred compensation;
|
|
|
|
Perquisites; and
|
|
|
|
Employee benefits, including
|
|
|
|
|
|
Health and insurance plans, and
|
|
|
|
Retirement benefits.
|
How We
Determine Each Element of Compensation and Why We Pay Each
Element
General. In the following section, we discuss
each element of compensation listed above, why we elect to pay
each element of compensation and how each element of
compensation was determined by the Compensation Committee. In
determining the amounts of each element and the aggregate
compensation for our Named Executive Officers, we do not use any
specific formulae or attempt to satisfy any specific ratio for
compensation among our executive officers. We also do not
generally target any particular allocation for base salary,
annual incentive, or long-term equity awards as a percent of
total compensation. The Compensation Committee has not engaged
in any formal benchmarking processes with respect to
compensation of Named Executive Officers. The Compensation
Committee has instead relied on the general knowledge,
experience and good judgment of its members, both with regard to
competitive compensation levels and the relative success that
our company has achieved.
Pay decisions for our Named Executive Officers are based on a
reasoned, subjective assessment of objective and subjective
factors that are weighted as follows:
|
|
|
|
|
two-thirds based on a consideration of our performance during a
given year against our budgeted performance as determined during
our annual budgeting process; and
|
|
|
|
one-third based on an assessment of individual factors with
respect to the particular Named Executive Officer.
|
16
For the two-thirds based on our budgeted performance goals, the
Compensation Committee considers each of four factors. The
Compensation Committee believes these factors are appropriate
measures in determining whether the objectives of our
compensation programs are being met. In particular, the
Compensation Committee considers:
|
|
|
|
|
our actual combined ratio compared to budgeted combined ratio;
|
|
|
|
our actual return on equity compared to budgeted return on
equity;
|
|
|
|
our actual total underwriting profit compared to budgeted total
underwriting profit; and
|
|
|
|
our actual net investment income compared to budgeted net
investment income.
|
For the one-third based on an assessment of individual factors,
the Compensation Committee considers:
|
|
|
|
|
the executives individual performance;
|
|
|
|
the executives future potential;
|
|
|
|
the executives years of service;
|
|
|
|
the executives level of experience;
|
|
|
|
the executives areas of responsibility; and
|
|
|
|
the executives total compensation opportunities relative
to compensation opportunities of other members of management of
HCC and its subsidiaries.
|
Because of the significant incentive opportunities available to
managers of our subsidiaries based on the subsidiarys
performance, the Compensation Committee also evaluates total
compensation to our Named Executive Officers to ensure overall
fairness between the compensation opportunities available at
both the subsidiary and the corporate level. The differences in
the aggregate compensation between our Chief Executive Officer,
our President and Chief Operating Officer, and our other Named
Executive Officers reflect the greater relative responsibilities
with respect to their respective positions.
Base Salary. Base salary provides a fixed base
level of compensation for our executives for the services they
render during the year. The purpose of base salary is to
compensate our Named Executive Officers in light of their
respective roles and responsibilities over time. Base salary is
essential to allow us to compete in the employment marketplace
for talent and is an important component of total compensation
for the Named Executive Officers. It is vital to our goal of
recruiting and retaining executive officers with proven
abilities. The level of base salary for each Named Executive
Officer was established in the executive officers
employment agreement upon the date of hire or the date of
renewal of an existing employment agreement. Base salary was
initially determined for each executive officer based on the
abilities, qualifications, accomplishments, and prior work
experience of the executive officer. Base salary in a renewal
agreement was determined based on the same criteria, but also on
how the executive officer performed under his previously
existing agreement and on the length of the executive
officers tenure with HCC.
While upward adjustments of base salary are generally specified
in the executive officers employment agreement,
adjustments may also be considered on a discretionary basis
annually. In deciding whether to make a discretionary increase
to a Named Executive Officers compensation, we consider
the consistency of the executive officers individual
performance over the prior year, changes in the executive
officers responsibilities, the executive officers
future potential and internal equity. We also consider data
available from objective, professionally-conducted market
studies obtained from a range of industry and general market
sources.
In 2008, Mr. Bramanti entered into an amended and restated
employment agreement to alleviate the potential adverse effects
of Internal Revenue Code Section 409A and to harmonize
employment terms among our executive officers. Mr. Moulton
agreed to amend his employment agreement during 2008 in
connection with his assumption of the role of Executive Vice
President U.S. Property and Casualty Operations
and his relocation to our corporate offices in Houston. See
Employment Agreements and Potential Payments Upon
Termination or Change of Control, below, for further
discussion of the terms of the employment contracts of our Named
Executive Officers.
Base salary for 2008 and increases, if any, for 2009 were set in
accordance with the terms of the respective employment
agreements of our Named Executive Officers. These increases are
shown in the Summary
17
Compensation Table, below. Our Board did not award any
discretionary salary increases under existing employment
agreements in 2008 or for 2009; however, Mr. Moulton
received a base salary increase of $125,000 or 31.3% in
connection with his entering into an amended employment
agreement. Our Compensation Committee deemed this increase
appropriate to compensate Mr. Moulton for the increased
responsibilities related to his new position with HCC, to serve
our retention goals with respect to Mr. Moulton, and to
achieve equity, both among similarly situated Named Executive
Officers and among our executives at the corporate level and at
the subsidiary level. Based upon their reasoned subjective
assessment of the market as well as data available from
objective, professionally-conducted market studies obtained from
a range of industry and general market sources, the members of
the Committee deemed the increase to be reasonable.
Annual Incentives. Annual incentive
compensation is intended to motivate and reward our Named
Executive Officers for performance in achieving our business
objectives.
2008 Flexible Incentive Plan. In 2008,
our Board adopted and our shareholders approved the HCC
Insurance Holdings, Inc. 2008 Flexible Incentive Plan. Under the
2008 Plan, we pay performance awards in the form of annual cash
incentive compensation payments. The 2008 Plan is intended to
advance our interests and those of our shareholders,
|
|
|
|
|
by rewarding superior performance;
|
|
|
|
by motivating our Named Executive Officers;
|
|
|
|
by attracting and retaining key executives; and
|
|
|
|
by fostering accountability and teamwork.
|
Under the 2008 Plan, we grant awards of incentive compensation
that may be paid to a participant upon our satisfaction of
corporate performance goals. We limit cash performance awards
under the 2008 Plan to our Chief Executive Officer and any of
our other employees whose compensation is potentially subject to
the deductibility limitations of Section 162(m) of the
Internal Revenue Code. Participants are designated by our
Compensation Committee. For 2008, Messrs. Bramanti, Ellis,
Molbeck and Kelbel participated in cash performance awards under
the 2008 Plan. Mr. Moulton did not participate because he
was not expected to be subject to Section 162(m) for 2008.
Our Compensation Committee established maximum bonus amounts for
each of these executives, expressed as a percentage of pretax
income for HCC. Those maximum targets were as follows:
Mr. Bramanti 1.0%, Mr. Ellis
0.25%, Mr. Molbeck 0.5% and
Mr. Kelbel 0.1%. For 2008, our pretax income
was $436.3 million. After the conclusion of the calendar
year, the Compensation Committee calculates the maximum bonus
amount based on the compensation targets established for each
executive officer and then determines the actual bonus payment
amounts based on a reasoned, subjective assessment of objective
and subjective factors (including actual operating results
against budget, the achievement of personal objectives,
individual performance and equitable considerations among
similarly situated executives) to arrive at the actual bonus
amount for a particular executive officer, which in each case is
equal to or less than the maximum bonus amount under the plan.
Our Compensation Committee uses negative discretion
in determining the actual annual cash incentive awards for the
participants in the 2008 Plan as allowed under
Section 162(m). For purpose of Section 162(m), the
maximum annual incentive award is determined to the extent we
achieve our performance goal of pretax income. The Compensation
Committee then exercises its negative discretion to reduce the
actual annual incentive awards to reflect actual corporate,
business unit and individual performance. By setting a high
amount that can then be reduced, we believe our annual incentive
payments qualify for full deductibility under
Section 162(m). Any reduction is not a negative reflection
on the performance of our company or our Named Executive
Officers, but rather is done to ensure maximum flexibility with
respect to the payment of performance-based bonuses. If the
Compensation Committee were to have instead funded the incentive
pool at a minimum threshold and used discretion to increase the
amounts to reflect company and individual performance, actual
payouts would not qualify for the Section 162(m) tax
deduction. For further information on Section 162(m), see
the description of Section 162(m) on page 21 of this
proxy statement.
Discretionary Annual Incentive. Named
Executive Officers who are not participants in the 2008 Plan are
eligible for a discretionary annual incentive award. These
discretionary annual bonuses are designed to advance our
18
interests and those of our shareholders and to achieve the same
goals as those set forth in the discussion of the 2008 Plan,
above, in that they reward, motivate, attract and retain key
executives and foster accountability and teamwork.
Mr. Moultons annual cash bonus for 2008 was subject
to the discretion of the CEO and the Compensation Committee.
Mr. Moulton was entitled to and received a minimum annual
bonus for 2008 of $400,000 under the terms of the amended and
restated employment agreement he entered into in connection with
his relocation to Houston and assumption of the duties of
Executive Vice President U.S. Property and
Casualty Operations.
For 2008, we determined the actual payouts under our 2008 Plan
and the actual amount of the discretionary bonus for
Mr. Moulton based on individual performance and company
performance, including the following factors:
|
|
|
|
|
Combined ratio of 85.4% against budget of 85.1%;
|
|
|
|
Return on average equity for 2008 of 12.0% against budget of
13.8%;
|
|
|
|
Total underwriting profits of $544.6 million against budget
of $552.9 million;
|
|
|
|
Overall investment results of $164.8 million against budget
of $218.2 million;
|
|
|
|
Individual effort by the executive in assisting us to achieve
our goals;
|
|
|
|
Our performance relative to peers;
|
|
|
|
Our performance in 2008 relative to prior years;
|
|
|
|
Our performance given the general conditions in the industry;
|
|
|
|
Equitable considerations among similarly situated
officers; and
|
|
|
|
Past bonus compensation.
|
No formula was applied to these measures in arriving at the
actual bonus amounts, although performance against budget was
weighted roughly two-thirds against one-third for individual
factors.
Taking these factors into account and utilizing reasoned,
subjective judgment, the Compensation Committee approved bonus
payments as follows: Mr. Bramanti $1,500,000;
Mr. Ellis $400,000;
Mr. Molbeck $1,950,000;
Mr. Moulton $400,000; and
Mr. Kelbel $450,000. Thirty-three percent of
the bonus to Messrs. Bramanti and Molbeck was in shares of
our common stock, which each of the executives has agreed to
retain for so long as he remains an employee of HCC. The
Committee believes that the grant of a portion of the bonus in
HCC stock serves the goals of our compensation program of
aligning the executives interests with those of our
shareholders and providing executives with the opportunity to
obtain a significant stake in our company. In each case, for
participants in the 2008 Plan, the actual bonus paid was less
than the target amount established under the Plan.
Long-Term Equity Awards. We have historically
granted stock options, as we believe this element of
compensation aligns the employees and the executive
officers interests with the long-term interests of
shareholders. We believe that stock options provide incentive
for increased shareholder value because they only provide value
to the Named Executive Officers to the extent that the price of
our common stock appreciates, and they serve as a good retention
vehicle for the Named Executive Officers because they vest based
on the executive officers continued employment. We also
grant restricted stock awards that generally cliff vest at a
later date. These long-term equity awards also serve the goal of
allowing our executives to obtain a significant stake in our
company.
In 2008, in connection with his amended and restated employment
agreement, we granted 100,000 stock options and
21,857 shares of restricted stock to Mr. Moulton. In
determining the amount of these grants, the Compensation
Committee considered prior grants made to Mr. Moulton and
those to similarly situated executives, the potential value of
the awards, the cost of the awards to us and general market
conditions and then utilized reasoned, subjective judgment to
arrive at a final award. The exercise price of the grant of
stock options and the fair value of the restricted shares was
set at the closing price of our common stock on the date of the
Compensation Committee meeting at which such grants were
approved.
19
We have granted each executive officer an equity award in
connection with his entering a new employment agreement or
amending a prior employment agreement with us. Additional equity
awards may be made at one of our regularly scheduled
Compensation Committee meetings during the year, which are
typically held within 30 days of our quarterly earnings
releases. The Compensation Committees policy is to set the
exercise price of stock option awards at the closing price of
our stock on the date of the Compensation Committee meeting at
which such options are granted. We do not coordinate the grant
of awards with the release of earnings for any purpose,
including the purpose of affecting the value of executive
compensation.
Non-qualified Deferred Compensation. Each of
Messrs. Bramanti and Molbeck are entitled to the payment of
deferred compensation under the terms of his respective
employment agreement. We believe the tax benefit bestowed on
these executives by our deferring payment of a portion of their
compensation is valuable to the executives and assists us in
meeting our retention goals. Paying a portion of their base
compensation as deferred compensation also ensures their
compensation will be fully tax deductible. Consequently, we have
adopted non-qualified deferred compensation plans for each of
Mr. Bramanti and Mr. Molbeck. The plans are
substantially identical and are discussed in more detail under
the caption Deferred Compensation Plans, below.
Perquisites. Our current policy is that the
costs of perquisites will constitute only a small percentage of
each Named Executive Officers total compensation. In
general, the perquisites that an executive officer is eligible
to receive are contained in such executives employment
agreement. In some instances, our Named Executive Officers were
provided perquisites by their previous employers, and we offered
comparable perquisites in order to attract these Named Executive
Officers. Perquisites may include: extended medical benefits; a
corporate apartment; an automobile allowance; personal travel on
the corporate aircraft; payment of club dues; payment of life
and disability insurance premiums; physical exams and payment
for estate planning. These benefits are reflected in the All
Other Compensation Column of the Summary Compensation Table,
below.
Employee Benefits. Our Named Executive
Officers have the opportunity to participate in a number of
benefit programs that are generally available to all of our
U.S. employees. The Named Executive Officers are eligible
to participate in company-sponsored benefit programs on the same
terms and conditions as those generally provided to other
salaried employees; however, in some instances described below,
the executives are entitled to additional benefits. These
benefits include:
Health and Insurance Plans. Basic
health benefits, dental benefits, disability protection, life
insurance, and similar programs are provided to make certain
that access to healthcare and income protection is available to
our employees and the employees family members. The cost
of company-sponsored benefit programs is negotiated by us with
the providers of such benefits. In general, the Named Executive
Officers contribute to the cost of the benefits; however,
medical benefits are provided to Messrs. Bramanti and
Molbeck at no cost to them.
In addition, under the terms of their respective employment
agreements, each of Messrs. Bramanti, Ellis, Molbeck and
Kelbel and their respective qualified beneficiaries, where
applicable, is entitled to extended medical benefits under our
medical plan after termination of their respective employment.
In the case of Messrs. Ellis and Kelbel, such benefits are
at no cost to them and extend until they or their respective
spouses become eligible for Medicare or the date their
respective children would have ceased to be covered under our
benefit plans had the executive remained an employee. For each
of Messrs. Bramanti and Molbeck, such benefits are at no
cost and extend until the later to occur of his death, the death
of his spouse (if he is married on the date of his death) or the
date their respective children would have ceased to be covered
under our benefit plans had the executive remained an employee.
We agreed to provide such extended medical benefits to
Mr. Bramanti and Mr. Molbeck during each of their
previous terms of employment with us.
Retirement Benefits. The Named
Executive Officers are eligible to participate in our 401(k)
Plan, which is a company-wide, tax-qualified retirement plan.
The intent of this plan is to provide all employees with a
tax-advantaged savings opportunity for retirement. We sponsor
this plan to help employees at all levels save and accumulate
assets for use during their retirement. As required, eligible
pay under this plan is capped at Internal Revenue Code annual
limits.
20
How We
Determine Executive Officer Compensation
Role of the Compensation Committee. The
Compensation Committee is composed of independent, outside
members of the Board of Directors in accordance with NYSE rules,
current SEC regulations, and Section 162(m) of the Internal
Revenue Code and is responsible for establishing, reviewing,
approving, and monitoring the compensation paid to the Named
Executive Officers.
Under our current policy, the Compensation Committee approves
the terms of each Named Executive Officers employment
agreement and any necessary modifications that are needed over
time.
The Chief Executive Officer recommends to the Compensation
Committee annual pay increases, discretionary annual bonuses,
cash incentive awards and long-term incentive grants for the
other Named Executive Officers. The Compensation Committee then
evaluates each executive officer, determines whether the CEO
will receive any annual pay increase, sets performance criteria
for discretionary annual incentive bonuses, and makes long-term
incentive grants, if any. As part of its evaluation process, the
Compensation Committee considers our performance, internal
equity and consistency, the executive officers individual
performance over the prior year, changes in responsibilities,
and future potential as well as data available from objective,
professionally-conducted market studies obtained from a range of
industry and general market sources.
The Compensation Committee views the various components of
compensation as related, but distinct. As a result, the
Compensation Committee has not adopted any policy or guidelines
for allocating compensation between long-term and currently paid
compensation, between cash and non-cash compensation, or among
different forms of non-cash compensation.
Benchmarking. The Compensation Committee did
not use benchmarking to set executive compensation in 2008.
Compensation Consultant. The Compensation
Committee may retain and engage, at its sole discretion, to the
extent deemed necessary and appropriate, any compensation
consultants, outside counsel or other advisors, having the sole
authority to approve the firms or advisors fees and
other retention. The Compensation Committee did not engage a
compensation consultant in 2008.
Other
Important Compensation Policies Affecting the Named Executive
Officers
Financial Restatement. The Compensation
Committee does not have a policy in place governing retroactive
modifications to any cash- or equity-based incentive
compensation paid to the Named Executive Officers where the
payment of such compensation was predicated upon the achievement
of specified financial results that were subsequently the
subject of a restatement. However, if the Compensation Committee
deems it appropriate and to the extent permitted by applicable
law, it will seek to recoup amounts, determined to have been
inappropriately paid to an executive officer as a result of a
financial restatement.
Stock Ownership Requirements. The Compensation
Committee does not maintain a policy relating to stock ownership
guidelines or requirements for its Named Executive Officers. The
Compensation Committee is reviewing whether such a policy is
appropriate for its Named Executive Officers.
Trading in Our Stock Derivatives. Our Insider
Trading Policy prohibits our employees, including Named
Executive Officers, from purchasing or selling options on our
common stock, engaging in short sales with respect to our common
stock, or trading in puts, calls, straddles, equity swaps or
other derivative securities that are directly linked to our
common stock.
Tax Deductibility of the Named Executive Officers
Incentive and Equity
Compensation. Section 162(m) of the Internal
Revenue Code generally disallows a tax deduction to public
companies for compensation over $1.0 million paid to a
corporations chief executive officer and the three other
most highly compensated executive officers, excluding the chief
financial officer.
Section 162(m) further provides that qualifying
performance-based compensation will not be subject to the
deduction limit if certain requirements are met. We currently
structure our discretionary annual incentive compensation for
executive officers to comply with Section 162(m) through
the 2008 Flexible Incentive Plan.
21
Our current annual incentives satisfy Section 162(m)s
requirement that they be payable solely on account of the
attainment of one or more performance goals. Although we
intend to structure grants under future stock award plans and
cash incentive plans in a manner that complies with this
section, we may forego all or some portion of a deduction to
conform to our compensation goals.
In connection with the compensation of our executive officers,
the Compensation Committee is aware of Section 162(m) as it
relates to deductibility of qualifying compensation paid to
executive officers. In addition, we are aware of recently
adopted Section 409A of the Internal Revenue Code and
believe we should structure our compensation plans in ways to
minimize the likelihood that our employees, including Named
Executive Officers, have to pay the excise taxes set forth under
Section 409A. If any provision of an employment agreement
we have entered into would cause the Named Executive Officer to
incur any additional tax under Section 409A or any Treasury
Regulations or IRS guidance, we will attempt to reform such
provision in a manner that maintains, to the extent possible,
the original intent of the provision without violating
Section 409A. In addition, the employment agreements of
Messrs. Bramanti, Molbeck, Ellis and Kelbel require us to
reimburse the executives for any 409A excise taxes incurred by
the executives in the event their employment agreements are not
fully 409A-compliant.
In addition, the future exercise of certain options held by
Named Executive Officers, which were issued at a grant date
price that was less than the measurement date price, may have
resulted in compensation to our Named Executive Officers that
exceeds the deductibility limitations under Section 162(m).
In connection with our stock option review in 2006, we repriced
these options before December 31, 2006 so that the grant
date price equals the measurement date price. However,
notwithstanding such repricing, these options no longer qualify
as qualified performance-based compensation under
Section 162(m). Therefore, to the extent a Named Executive
Officer were to exercise such options during a given year, any
gain realized on such exercise would be included in the
calculation of non-excluded compensation, and we would not be
able to deduct any such compensation that exceeds the
deductibility limits. Thus, future option exercise activity that
is beyond our control or the Compensation Committees
control could cause non-deductible compensation expense under
Section 162(m). This risk will remain until all such
repriced options are exercised, terminated or expire.
Change of Control Agreements. Our executive
officers employment agreements provide for severance in
the event of change of control. Except for
Mr. Molbecks agreement, payments will only be made
under these agreements if there is both a change of control and
a termination of employment. This is discussed in more detail
under the caption Employment Agreements and Potential
Payments Upon Termination or Change of Control below. The
Compensation Committee believes this benefit is required to
offer competitive benefits to attract and retain highly
qualified executives.
Mr. Molbeck is the only Named Executive Officer who
currently will be entitled to a payment sufficient to reimburse
him fully on an after-tax basis for any tax under
Section 4999 of the Internal Revenue Code, as well as any
costs associated with resolving the application of such tax to
him.
COMPENSATION
COMMITTEE REPORT
The Compensation Committee has reviewed and discussed the
Compensation Discussion and Analysis with management. Based upon
such review, the related discussions and such other matters
deemed relevant and appropriate to the Compensation Committee,
the Compensation Committee has recommended to the Board of
Directors that the Compensation Discussion and Analysis be
included in this Proxy Statement to be delivered to shareholders.
Submitted by the Compensation Committee:
James E. Oesterreicher, Chairman
Thomas M. Hamilton
Christopher J. B. Williams
22
Summary
of Cash and Certain Other Compensation
The following table provides certain information concerning
compensation we paid to or accrued on behalf of our Principal
Executive Officer, Principal Financial Officer and the other
three most highly compensated executive officers serving at
December 31, 2008, who are sometimes referred to in this
Proxy Statement collectively as the Named Executive
Officers.
2008
Summary Compensation Table
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incentive
|
|
|
Non-qualified
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock
|
|
|
Option
|
|
|
Plan
|
|
|
Deferred
|
|
|
All Other
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Awards
|
|
|
Awards
|
|
|
Compensation
|
|
|
Compensation
|
|
|
Compensation
|
|
|
|
|
Name and Principal Position
|
|
Year
|
|
|
Salary ($)
|
|
|
Bonus ($)
|
|
|
($)(1)
|
|
|
($)(2)
|
|
|
($)(3)
|
|
|
Earnings ($)
|
|
|
($)(4)
|
|
|
Total ($)
|
|
|
Frank J. Bramanti
|
|
|
2008
|
|
|
|
1,950,000
|
(5)
|
|
|
|
|
|
|
494,983
|
|
|
|
753,614
|
|
|
|
1,005,017
|
|
|
|
1,670
|
|
|
|
32,958
|
|
|
|
4,238,242
|
|
Chief Executive Officer
|
|
|
2007
|
|
|
|
1,950,000
|
(5)
|
|
|
|
|
|
|
|
|
|
|
626,930
|
|
|
|
1,950,000
|
|
|
|
8,393
|
|
|
|
32,762
|
|
|
|
4,568,085
|
|
|
|
|
2006
|
|
|
|
250,000
|
|
|
|
250,000
|
|
|
|
|
|
|
|
71,160
|
|
|
|
|
|
|
|
|
|
|
|
219,640
|
|
|
|
790,800
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Edward H. Ellis, Jr.
|
|
|
2008
|
|
|
|
525,000
|
|
|
|
|
|
|
|
|
|
|
|
449,100
|
|
|
|
400,000
|
|
|
|
|
|
|
|
20,928
|
|
|
|
1,395,028
|
|
Executive Vice President and
|
|
|
2007
|
|
|
|
491,667
|
|
|
|
|
|
|
|
|
|
|
|
483,565
|
|
|
|
500,000
|
|
|
|
|
|
|
|
19,240
|
|
|
|
1,494,472
|
|
Chief Financial Officer
|
|
|
2006
|
|
|
|
425,000
|
|
|
|
425,000
|
|
|
|
|
|
|
|
588,848
|
|
|
|
|
|
|
|
|
|
|
|
20,076
|
|
|
|
1,458,924
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
John N. Molbeck, Jr.
|
|
|
2008
|
|
|
|
1,350,000
|
(6)
|
|
|
|
|
|
|
643,483
|
|
|
|
709,191
|
|
|
|
1,306,517
|
|
|
|
491
|
|
|
|
96,867
|
|
|
|
4,106,549
|
|
President and
|
|
|
2007
|
|
|
|
1,253,035
|
(6)
|
|
|
|
|
|
|
|
|
|
|
625,666
|
|
|
|
2,500,000
|
|
|
|
1,319
|
|
|
|
91,234
|
|
|
|
4,471,254
|
|
Chief Operating Officer
|
|
|
2006
|
|
|
|
838,103
|
(6)
|
|
|
150,000
|
|
|
|
|
|
|
|
453,293
|
|
|
|
250,000
|
|
|
|
|
|
|
|
185,541
|
|
|
|
1,876,937
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cory L. Moulton
|
|
|
2008
|
|
|
|
441,667
|
|
|
|
400,000
|
|
|
|
47,793
|
|
|
|
260,893
|
|
|
|
|
|
|
|
|
|
|
|
928,587
|
|
|
|
2,078,940
|
|
Executive Vice President
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Property & Casualty Operations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Craig J. Kelbel
|
|
|
2008
|
|
|
|
612,000
|
|
|
|
13,700
|
|
|
|
|
|
|
|
545,910
|
|
|
|
436,300
|
|
|
|
|
|
|
|
51,589
|
|
|
|
1,659,499
|
|
Executive Vice President
|
|
|
2007
|
|
|
|
585,000
|
|
|
|
|
|
|
|
|
|
|
|
494,193
|
|
|
|
367,200
|
|
|
|
|
|
|
|
220,323
|
|
|
|
1,666,716
|
|
U.S. Accident & Health Operations
|
|
|
2006
|
|
|
|
450,000
|
|
|
|
250,000
|
|
|
|
|
|
|
|
400,778
|
|
|
|
|
|
|
|
|
|
|
|
66,026
|
|
|
|
1,166,804
|
|
|
|
|
(1) |
|
Mr. Bramanti and Mr. Molbeck each received 33% of his
annual incentive compensation in shares of HCC stock under the
2008 Flexible Incentive Plan. On February 17, 2009,
Messrs. Bramanti and Molbeck were granted 20,676 and
26,879 shares, respectively. Each of the executives has
agreed not to dispose of these shares for so long as he remains
an employee of HCC. On August 20, 2008, Mr. Moulton
was granted 21,857 shares of restricted stock. This column
includes the expense we recognized in our 2008 consolidated
income statement under Statement of Financial Accounting
Standards No. 123(R), Share-Based Payment. For a
discussion of the assumptions used in calculating the fair value
of our stock-based compensation, refer to Note 1,
General Information and Significant Accounting and Reporting
Policies Stock-Based Compensation, and
Note 11, Stock-Based Compensation, in the Notes to
Consolidated Financial Statements contained in our Annual Report
on
Form 10-K
for the year ended December 31, 2008. |
|
(2) |
|
Stock options that were granted to our Named Executive Officers
in 2008 and in prior years generally vest over periods of one to
five years. A grant to Mr. Bramanti in 2007 will vest in
2011 based upon our achievement of average return on equity for
the four-year period of 2007 through 2010. This column includes
the expense we recognized in our 2008, 2007 and 2006
consolidated income statements under Statement of Financial
Accounting Standards No. 123(R), Share-Based
Payment. For a discussion of the assumptions used in
calculating the fair value of our option awards, refer to
Note 1, General Information and Significant Accounting
and Reporting Policies Stock-Based Compensation,
and Note 11, Stock-Based Compensation, in the Notes
to Consolidated Financial Statements contained in our Annual
Report on
Form 10-K
for the year ended December 31, 2008. |
|
(3) |
|
The amounts for 2008 represent cash incentive awards under our
2008 Flexible Incentive Plan. |
|
(4) |
|
For 2008, these amounts include matching 401(k) contributions,
life and disability premiums, personal use of corporate
aircraft, auto expense, club dues, stock option make-whole
payment, corporate apartment, relocation expenses, aggregate
incremental cost of guaranteed resale of residence, cost of
company-provided physical |
23
|
|
|
|
|
exam and estate planning. Refer to All Other
Compensation table, immediately following, for disclosure
of amounts included in this column. |
|
(5) |
|
Salary for Mr. Bramanti for 2008 and 2007 includes
$1,000,000 in deferred compensation under the terms of
Mr. Bramantis employment agreement. See 2008
Non-qualified Deferred Compensation Plans below for
further information. |
|
(6) |
|
Salary for Mr. Molbeck for 2008 and 2007 includes $350,000
and $294,702, respectively, in deferred compensation under the
terms of Mr. Molbecks employment agreement and for
2006, includes $255,411 of deferred compensation under the terms
of a post-employment consulting arrangement with us under his
previous employment agreement. See 2008 Non-qualified
Deferred Compensation Plans below for further information. |
All
Other Compensation
The following table describes each component of the All Other
Compensation column in the Summary Compensation Table for 2008.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Life and
|
|
|
Personal Use
|
|
|
|
|
|
|
|
|
Stock Option
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Matching 401K
|
|
|
Disability
|
|
|
of Corporate
|
|
|
Auto
|
|
|
Club
|
|
|
Make Whole
|
|
|
Corporate
|
|
|
Relocation
|
|
|
Home
|
|
|
|
|
|
|
Contributions
|
|
|
Premiums
|
|
|
Aircraft
|
|
|
Expense
|
|
|
Dues
|
|
|
Payment
|
|
|
Apartment
|
|
|
Expenses
|
|
|
Purchase
|
|
|
Other
|
|
Name of Executive
|
|
($)(1)
|
|
|
($)(2)
|
|
|
($)(3)
|
|
|
($)(4)
|
|
|
($)
|
|
|
($)(5)
|
|
|
($)(6)
|
|
|
($)(7)
|
|
|
($)(8)
|
|
|
($)(9)
|
|
|
Frank J. Bramanti
|
|
|
10,200
|
|
|
|
21,483
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,275
|
|
Edward H. Ellis, Jr.
|
|
|
10,200
|
|
|
|
10,158
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
570
|
|
John N. Molbeck
|
|
|
10,200
|
|
|
|
11,414
|
|
|
|
30,628
|
|
|
|
36,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8,625
|
|
Cory L. Moulton
|
|
|
10,200
|
|
|
|
2,422
|
|
|
|
|
|
|
|
|
|
|
|
28,441
|
|
|
|
70,800
|
|
|
|
|
|
|
|
70,563
|
|
|
|
746,161
|
|
|
|
|
|
Craig J. Kelbel
|
|
|
10,200
|
|
|
|
3,192
|
|
|
|
|
|
|
|
|
|
|
|
10,300
|
|
|
|
|
|
|
|
26,792
|
|
|
|
|
|
|
|
|
|
|
|
1,105
|
|
|
|
|
(1) |
|
This column reports company matching contributions to each Named
Executive Officers 401(k) savings account of 6% of pay up
to the limitations imposed under our 401(k) plan. |
|
(2) |
|
This column reports taxable payments made to the Named Executive
Officers in the form of premiums for life and disability
insurance policies owned by or for the benefit of the executives. |
|
(3) |
|
This column includes the aggregate incremental cost for the
Named Executive Officers personal use of company aircraft.
The calculation includes the variable costs incurred as a result
of personal flight activity, including a portion of ongoing
maintenance and repairs, aircraft fuel, satellite communications
and any travel expenses for the flight crew. It excludes
non-variable costs, such as hangar expense, exterior paint,
interior refurbishment and regularly scheduled inspections,
which would have been incurred regardless of whether there was
any personal use of aircraft. This benefit is provided for under
the terms of Mr. Molbecks employment agreement. |
|
(4) |
|
This column reports taxable payments made to the Named Executive
Officer for certain automobile expenses. |
|
(5) |
|
This column reports amounts paid to Mr. Moulton in
connection with the repricing of certain options granted to
Mr. Moulton before 2008. |
|
(6) |
|
This column reports amounts paid to rent a corporate apartment
for Mr. Kelbel, which we agreed to provide under the terms
of his employment agreement. |
|
(7) |
|
This column reports relocation expenses paid to Mr. Moulton
in connection with his relocation to our corporate offices in
Houston and includes $12,292 for reimbursement of federal income
and FICA taxes. |
|
(8) |
|
This column reports compensation to Mr. Moulton as a result
of the gain in connection with our purchase of his home pursuant
to our agreement to guarantee the resale of his house in Mount
Kisco, New York in connection with his relocation to our
corporate offices in Houston and includes $245,753 for
reimbursement of federal income and FICA taxes. |
|
(9) |
|
This column reports the total amount of other benefits provided,
none of which individually exceeded the greater of $25,000 or
10% of the total amount of these benefits for the Named
Executive Officer. These other benefits include: cost of
company-provided physical exam and estate planning. |
24
Equity
Compensation Plan Information
The following table sets forth information as of
December 31, 2008, with respect to compensation plans under
which our equity securities are authorized for issuance. All
such plans were approved by our shareholders.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Securities
|
|
|
|
|
|
|
|
|
|
Remaining Available
|
|
|
|
Number of Securities
|
|
|
Weighted-Average
|
|
|
for Future Issuance Under
|
|
|
|
to be Issued Upon Exercise
|
|
|
Exercise Price of
|
|
|
Equity Compensation Plans
|
|
|
|
of Outstanding Options,
|
|
|
Outstanding Options,
|
|
|
(Excluding Securities
|
|
|
|
Warrants and Rights
|
|
|
Warrants and Rights
|
|
|
Reflected in Column (a))
|
|
Plan category
|
|
(a)
|
|
|
(b)
|
|
|
(c)
|
|
|
Equity compensation plans approved by security holders
|
|
|
8,381,527
|
(1)
|
|
$
|
26.41
|
|
|
|
4,700,482
|
|
|
|
|
(1) |
|
The total in this column includes 132,952 restricted stock units
issued under our equity incentive plan. These restricted stock
units are not included in the calculation of weighted-average
exercise price in column (b). |
2008
Grants of Plan Based Awards
The following table provides details regarding plan based awards
granted to the Named Executive Officers during 2008.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Estimated
|
|
|
Estimated
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Future
|
|
|
Future
|
|
|
All Other
|
|
|
All Other
|
|
|
|
|
|
|
|
|
|
|
|
|
Payouts Under
|
|
|
Payouts Under
|
|
|
Stock
|
|
|
Option
|
|
|
Exercise or
|
|
|
Grant Date
|
|
|
|
|
|
|
Non-Equity
|
|
|
Equity
|
|
|
Awards:
|
|
|
Awards:
|
|
|
Base
|
|
|
Fair Value
|
|
|
|
|
|
|
Incentive Plan
|
|
|
Incentive Plan
|
|
|
Number of
|
|
|
Number of
|
|
|
Price of
|
|
|
of Stock and
|
|
|
|
|
|
|
Awards
|
|
|
Awards
|
|
|
Shares of
|
|
|
Securities
|
|
|
Option
|
|
|
Option
|
|
|
|
|
|
|
Maximum
|
|
|
Maximum
|
|
|
Stocks or
|
|
|
Underlying
|
|
|
Awards
|
|
|
Awards
|
|
Name
|
|
Grant Date
|
|
|
($)(1)
|
|
|
($)(2)
|
|
|
Units (#)
|
|
|
Options (#)
|
|
|
($/Sh)
|
|
|
($/Sh)
|
|
|
Frank J. Bramanti
|
|
|
|
|
|
|
2,923,210
|
|
|
|
1,439,790
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Edward H. Ellis, Jr.
|
|
|
|
|
|
|
1,090,750
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
John N. Molbeck, Jr.
|
|
|
|
|
|
|
2,932,210
|
|
|
|
1,439,790
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cory L. Moulton
|
|
|
|
|
|
|
1,090,750
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
08/20/2008
|
|
|
|
|
|
|
|
|
|
|
|
21,857
|
(3)
|
|
|
|
|
|
|
24.02
|
|
|
|
525,005
|
|
|
|
|
08/20/2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100,000
|
(3)
|
|
|
24.02
|
|
|
|
425,800
|
|
Craig J. Kelbel
|
|
|
|
|
|
|
1,090,750
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
These amounts represent the potential maximum value of the cash
portion of the annual bonus awards for 2009, to be payable in
2010, under our 2008 Flexible Incentive Plan for
Messrs. Bramanti, Ellis, Molbeck, Kelbel and Moulton. These
amounts are an estimate of the maximum potential cash payout for
2009, based on the maximum bonus targets for 2009
(Mr. Bramanti (1.0%), Mr. Ellis (0.25%),
Mr. Molbeck (1.0%), Mr. Moulton (0.25%) and
Mr. Kelbel (0.25%)) and our pretax income actually achieved
in 2008 ($436.3 million). For Messrs. Bramanti and
Molbeck, 67% of the total incentive bonus was paid in cash and
33% in stock; therefore, the amount set forth in this column is
equal to 67% of the maximum. The actual amounts of cash bonus
awards paid for performance during 2008 to Mr. Bramanti
($1,005,017), Mr. Ellis ($400,000), Mr. Molbeck
($1,306,517) and Mr. Kelbel ($436,300) are reported in the
Non-Equity Incentive Plan Compensation column of the Summary
Compensation Table, above. Mr. Moulton did not participate
in the Plan during 2008. |
|
|
|
Our 2008 Flexible Incentive Plan provides a performance bonus
based upon our achievement of pretax income. The Compensation
Committee establishes maximum bonus amounts for eligible Named
Executive Officers at the start of the year in order to ensure
the bonus amounts meet the requirements for performance-based
compensation under Section 162(m) of the Internal Revenue
Code of 1986. After the conclusion of the calendar year, the
Compensation Committee calculates the maximum total bonus amount
based on the compensation targets established for each executive
officer and then determines the actual bonus payment amounts
based on a reasoned, subjective assessment of objective and
subjective factors (including actual operating results against
budget, the achievement of personal objectives, individual
performance and equitable considerations among |
25
|
|
|
|
|
similarly situated executives) to arrive at the actual bonus
amount for a particular executive officer, which in each case is
equal to or less than the maximum bonus amount under the plan. |
|
(2) |
|
These amounts represent the potential maximum value of the stock
portion of the annual bonus awards for 2009, to be payable in
2010, under our 2008 Flexible Incentive Plan for
Messrs. Bramanti and Molbeck. As noted above, 33% of the
total annual bonus payable to Messrs. Bramanti and Molbeck
under our 2008 Flexible Incentive Plan was paid in shares of our
common stock; therefore the amount set forth above is equal to
33% of the maximum. These amounts are an estimate of the maximum
potential stock payout for 2009, based on the maximum bonus
targets for 2009 and the pretax income actually achieved in
2008. The actual amounts of stock bonus awards paid to
Mr. Bramanti ($494,983) and Mr. Molbeck ($643,483) for
2008 are reported in the Stock Awards column of the Summary
Compensation Table, above. |
|
(3) |
|
In connection with his execution of a new employment agreement
and relocation to Houston, Mr. Moulton received a grant of
100,000 options at an exercise price of $24.02, which vest over
five years and have a six-year term, and a grant of
21,857 shares of restricted stock with a four-year cliff
vesting schedule. |
2008
Outstanding Equity Awards at Fiscal Year End
The following table contains information with respect to
outstanding option and stock awards at December 31, 2008.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Option Awards
|
|
|
Stock Awards
|
|
|
|
|
|
|
|
|
|
Equity Incentive
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Plan
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Awards:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
|
Number of
|
|
|
Securities
|
|
|
|
|
|
|
|
|
Number of
|
|
|
|
|
|
|
Securities
|
|
|
Securities
|
|
|
Underlying
|
|
|
|
|
|
|
|
|
Shares of Stock
|
|
|
Market Value of
|
|
|
|
Underlying
|
|
|
Underlying
|
|
|
Unexercised
|
|
|
|
|
|
|
|
|
or Units of Stock
|
|
|
Shares or Units
|
|
|
|
Unexercised
|
|
|
Unexercised
|
|
|
Unearned
|
|
|
Option
|
|
|
Option
|
|
|
That Have Not
|
|
|
of Stock That
|
|
|
|
Options
|
|
|
Options
|
|
|
Options
|
|
|
Exercise Price
|
|
|
Expiration
|
|
|
Vested
|
|
|
Have Not Vested
|
|
Name
|
|
(#) Exercisable
|
|
|
(#) Unexercisable
|
|
|
(#)
|
|
|
($)(1)
|
|
|
Date
|
|
|
(#)
|
|
|
(#)
|
|
|
Frank J. Bramanti(2)
|
|
|
|
|
|
|
|
|
|
|
100,000
|
|
|
|
31.11
|
|
|
|
3/2/2012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
50,000
|
|
|
|
|
|
|
|
31.11
|
|
|
|
3/2/2012
|
|
|
|
|
|
|
|
|
|
|
|
|
100,000
|
|
|
|
300,000
|
|
|
|
|
|
|
|
31.11
|
|
|
|
3/2/2012
|
|
|
|
|
|
|
|
|
|
|
|
|
12,500
|
|
|
|
|
|
|
|
|
|
|
|
30.85
|
|
|
|
1/5/2011
|
|
|
|
|
|
|
|
|
|
|
|
|
18,750
|
|
|
|
|
|
|
|
|
|
|
|
21.37
|
|
|
|
12/20/2009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Edward H. Ellis, Jr.(3)
|
|
|
33,333
|
|
|
|
16,667
|
|
|
|
|
|
|
|
31.92
|
|
|
|
5/9/2011
|
|
|
|
|
|
|
|
|
|
|
|
|
33,333
|
|
|
|
16,667
|
|
|
|
|
|
|
|
33.18
|
|
|
|
4/10/2011
|
|
|
|
|
|
|
|
|
|
|
|
|
75,000
|
|
|
|
25,000
|
|
|
|
|
|
|
|
28.53
|
|
|
|
9/28/2011
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
John N. Molbeck, Jr.(4)
|
|
|
75,000
|
|
|
|
75,000
|
|
|
|
|
|
|
|
31.92
|
|
|
|
5/9/2012
|
|
|
|
|
|
|
|
|
|
|
|
|
133,332
|
|
|
|
66,668
|
|
|
|
|
|
|
|
33.56
|
|
|
|
3/23/2011
|
|
|
|
|
|
|
|
|
|
|
|
|
12,500
|
|
|
|
|
|
|
|
|
|
|
|
30.85
|
|
|
|
1/5/2011
|
|
|
|
|
|
|
|
|
|
|
|
|
22,500
|
|
|
|
15,000
|
|
|
|
|
|
|
|
24.47
|
|
|
|
4/4/2013
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cory L. Moulton(5)
|
|
|
|
|
|
|
100,000
|
|
|
|
|
|
|
|
24.02
|
|
|
|
8/20/2014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
21,857
|
|
|
|
584,675
|
|
|
|
|
|
|
|
|
67,500
|
|
|
|
|
|
|
|
23.71
|
|
|
|
4/28/2011
|
|
|
|
|
|
|
|
|
|
|
|
|
42,500
|
|
|
|
|
|
|
|
|
|
|
|
23.71
|
|
|
|
4/28/2010
|
|
|
|
|
|
|
|
|
|
|
|
|
30,000
|
|
|
|
20,000
|
|
|
|
|
|
|
|
27.56
|
|
|
|
7/22/2011
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Craig J. Kelbel(6)
|
|
|
25,000
|
|
|
|
75,000
|
|
|
|
|
|
|
|
31.92
|
|
|
|
5/9/2012
|
|
|
|
|
|
|
|
|
|
|
|
|
60,000
|
|
|
|
40,000
|
|
|
|
|
|
|
|
28.53
|
|
|
|
9/28/2011
|
|
|
|
|
|
|
|
|
|
|
|
|
75,000
|
|
|
|
|
|
|
|
|
|
|
|
23.83
|
|
|
|
12/31/2010
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Where applicable, the exercise price corresponds to our closing
stock price on the deemed grant date (the measurement date for
accounting purposes), as determined during our internal review
of our past option granting practices. |
26
|
|
|
(2) |
|
The vesting dates and amounts for options granted to
Mr. Bramanti that were unexercisable at December 31,
2008 are as follows: 100,000 options exercisable at $31.11 per
share vested on March 2, 2009; 100,000 options exercisable
at $31.11 per share will vest on March 2, 2010; 150,000
options exercisable at $31.11 per share will vest on
March 2, 2011; and up to 100,000 options exercisable at
$31.11 per share will vest within ten days of March 2, 2011
based upon our achievement of average return on equity for the
four-year period of 2007 through 2010. |
|
(3) |
|
The vesting dates and amounts for options granted to
Mr. Ellis that were unexercisable at December 31, 2008
are as follows: 16,667 options exercisable at $33.18 per share
vested on April 10, 2009; 25,000 options exercisable at
$28.53 per share will vest on September 28, 2009; and
16,667 options exercisable at $31.92 will vest on
December 31, 2009. |
|
(4) |
|
The vesting dates and amounts for options granted to
Mr. Molbeck that were unexercisable at December 31,
2008 are as follows: 66,668 options exercisable at $33.56 per
share vested on March 23, 2009; 7,500 options exercisable
at $24.47 per share vested on April 4, 2009; 37,500 options
exercisable at $31.92 per share will vest on December 31,
2009; 7,500 options exercisable at $24.47 per share will vest on
April 4, 2010; and 37,500 options exercisable at $31.92 per
share will vest on December 31, 2010. |
|
(5) |
|
The vesting dates and amounts for options granted to
Mr. Moulton that were unexercisable at December 31,
2008 are as follows: 10,000 options exercisable at $27.56 per
share will vest on July 22, 2009; 20,000 options
exercisable at $24.02 per share will vest on August 20,
2009; 67,500 options exercisable at $23.71 will vest on
April 28, 2010; 10,000 options exercisable at $27.56 per
share will vest on July 22, 2010; 20,000 options
exercisable at $24.02 per share will vest on August 20,
2010; 20,000 options exercisable at $24.02 per share will vest
on August 20, 2011; 20,000 options exercisable at $24.02
per share will vest on August 20, 2012; and 20,000 options
exercisable at $24.02 per share will vest on August 20,
2013. |
|
|
|
The vesting date for shares of restricted stock that were
unvested at December 31, 2008 are as follows:
21,857 shares vest on August 20, 2012. |
|
(6) |
|
The vesting dates and amounts for options granted to
Mr. Kelbel that were unexercisable at December 31,
2008 are as follows: 25,000 options exercisable at $31.92 per
share vested on February 28, 2009; 20,000 options
exercisable at $28.53 per share will vest on September 28,
2009; 25,000 options exercisable at $31.92 per share will vest
on February 28, 2010; 20,000 options exercisable at $28.53
per share will vest on September 28, 2010; and 25,000
options exercisable at $31.92 per share will vest on
February 28, 2011. |
2008
Option Exercises and Stock Vested Table
The following table contains information with respect to the
options exercised by the Named Executive Officers during 2008.
No stock awards to our Named Executive Officers vested in 2008.
|
|
|
|
|
|
|
|
|
|
|
Option Awards
|
|
|
|
Number of
|
|
|
|
|
|
|
Shares Acquired
|
|
|
Value Realized
|
|
|
|
on Exercise
|
|
|
on Exercise
|
|
Name
|
|
(#)
|
|
|
($)(1)
|
|
|
Frank J. Bramanti
|
|
|
18,750
|
|
|
|
149,250
|
|
Edward H. Ellis, Jr.
|
|
|
11,904
|
|
|
|
106,779
|
|
|
|
|
48,096
|
|
|
|
431,421
|
|
|
|
|
35,500
|
|
|
|
311,988
|
|
|
|
|
2,000
|
|
|
|
17,720
|
|
|
|
|
37,500
|
|
|
|
246,458
|
|
John N. Molbeck, Jr.
|
|
|
|
|
|
|
|
|
Cory L. Moulton
|
|
|
|
|
|
|
|
|
Craig J. Kelbel
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
The value realized is calculated by multiplying the spread
between the market price on the date of exercise and the
exercise price of the option by the number of shares acquired on
exercise. |
27
2008
Non-qualified Deferred Compensation Plans
The following table contains information with respect to the
non-qualified deferred compensation plans by the Named Executive
Officers during 2008.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Executive
|
|
Company
|
|
Aggregate
|
|
Aggregate
|
|
Aggregate
|
|
|
Contributions in
|
|
Contributions in
|
|
Earnings
|
|
Withdrawals/
|
|
Balance at
|
|
|
Last FY
|
|
Last FY
|
|
in Last FY
|
|
Distributions
|
|
Last FYE
|
Name
|
|
($)
|
|
($)
|
|
($)
|
|
($)
|
|
($)
|
|
Frank J. Bramanti
|
|
|
|
|
|
|
1,000,000
|
|
|
|
72,126
|
(1)
|
|
|
|
|
|
|
2,105,071
|
(2)
|
John N. Molbeck, Jr.
|
|
|
|
|
|
|
350,000
|
|
|
|
22,190
|
(3)
|
|
|
|
|
|
|
672,465
|
(4)
|
|
|
|
(1) |
|
Of this amount, $1,670 is considered above-market earnings under
SEC regulations and has been included in the Summary
Compensation table, above. Earnings on deferred compensation are
deemed above-market only if the rate exceeds 120% of the
applicable federal long-term rate, with compounding. |
|
(2) |
|
Of this amount, $1,008,393 was previously reported as
compensation to Mr. Bramanti in the Summary Compensation
Table for prior years. |
|
(3) |
|
Of this amount, $491 is considered above-market earnings under
SEC regulations and has been included in the Summary
Compensation table, above. Earnings on deferred compensation are
deemed above-market only if the rate exceeds 120% of the
applicable federal long-term rate, with compounding. |
|
(4) |
|
Of this amount, $296,021 was previously reported as compensation
to Mr. Molbeck in prior years. |
Deferred
Compensation Plans
Each of Mr. Bramanti and Mr. Molbeck receives deferred
compensation under his respective employment agreement. We have
implemented the HCC Insurance Holdings, Inc. Nonqualified
Deferred Compensation Plan for Frank J. Bramanti and the HCC
Insurance Holdings, Inc. Nonqualified Deferred Compensation Plan
for John N. Molbeck, Jr. under which this deferred
compensation is paid. The terms of the plans, which are
substantially identical except as noted below, are as follows.
The eligible participant under each plan is the individual
executive named in the plan, but only for so long as he remains
an employee of HCC. Monthly contributions are credited to the
participants account in an amount equal to one-twelfth of
the annual deferred compensation under the executives
employment agreement, and the Compensation Committee may also
make additional discretionary company contributions. The amount
credited to the executives account will accrue earnings,
which shall compound monthly, at the executives election,
which may be changed once per quarter, at one of the following
rates: the prime rate (4.875% for 2008), the rate of return on
HCC common stock (-4.85% for 2008), or the rate of return on the
S&P 500 (-37.00% for 2008). Payment of the executives
account balance will occur within 30 days of the
executives separation from service with HCC (subject to a
six-month delay if necessary in order to comply with Internal
Revenue Code Section 409A) and will be payable to the
executive (or in the event of the executives death, to the
executives beneficiary) in a single lump sum. Each plan is
administered by our Compensation Committee. No separate trust or
fund shall be created, and all benefits payable under the plans
will be paid from HCCs general assets.
Employment
Agreements and Potential Payments Upon Termination or Change of
Control
We have entered into employment agreements with our Chief
Executive Officer, Chief Financial Officer and the other Named
Executive Officers listed below. The employment agreements set
forth the general terms and conditions of each executive
officers employment. Each of the executives has the right
to voluntarily terminate his employment at any time.
We do not maintain a separate severance plan for our Named
Executive Officers. Severance benefits for our Named Executive
Officers are limited to those as set forth in the respective
Named Executive Officers employment agreement.
28
The following summarizes the terms of each of these agreements:
Frank
J. Bramanti
General. According to the terms of the Amended
and Restated Employment Agreement entered into on
December 17, 2008, which is effective as of January 1,
2007, Mr. Bramanti serves as our Chief Executive Officer.
Mr. Bramantis employment agreement expires on
December 31, 2010. Mr. Bramanti will receive an annual
salary of $1,950,000 (consisting of a base salary of $950,000
and deferred compensation of $1,000,000). In addition,
Mr. Bramanti will be eligible to receive bonus compensation
under the 2008 Flexible Incentive Plan. Mr. Bramanti and
his qualified beneficiaries are entitled to medical coverage at
no cost. Mr. Bramanti and his qualified beneficiaries are
entitled to extended medical coverage after termination of
Mr. Bramantis employment at the companys
expense. The benefits are to last until, in general, the later
of the date Mr. Bramanti or his spouse dies or, in the case
of Mr. Bramantis qualified beneficiaries, the date
such person would cease to be eligible for coverage under our
group health plan had Mr. Bramanti remained an employee
through the date such coverage lapses. He is also entitled to
supplementary term life insurance of $5,000,000 at company
expense. Mr. Bramantis employment agreement also
contains a provision under which he agrees to provide consulting
services for six months after the termination of the agreement
on December 31, 2010 for the sum of $300,000 payable in
monthly installments over the consulting term. If the agreement
is terminated, Mr. Bramanti has agreed to certain
provisions relating to non-competition (for two years
post-termination), confidentiality, and non-solicitation of
customers and employees (for two years post-termination).
Benefits Upon the Occurrence of Certain Termination
Events. In the event Mr. Bramantis
employment is terminated as a result of his death or disability,
he or his estate, as the case may be, will receive his accrued
salary and unreimbursed expenses through the date of
termination, a discounted lump sum equal to base salary and
deferred compensation for the lesser of 18 months or the
remainder of the term and a discounted lump sum amount, in lieu
of benefits other than medical, equal to $1,583 times the lesser
of 18 months or the number of months remaining in the term.
In the event Mr. Bramantis employment is terminated
by us without Cause, or by Mr. Bramanti for
Good Reason or by HCC for any reason other than
Cause after a Change of Control, in each
such case as set forth in the employment agreement,
Mr. Bramanti will receive his accrued salary and
unreimbursed expenses through the date of termination, a
discounted lump sum equal to base salary and deferred
compensation for the remainder of the employment agreement term,
a lump sum payment equal to $300,000 in lieu of the consulting
fee that would have been earned under the agreement had such
termination not occurred, and a discounted lump sum, in lieu of
benefits other than medical, equal to $1,583 times the number of
months remaining in the term. If his employment is terminated by
us for Cause or by Mr. Bramanti without
Good Reason, Mr. Bramanti will receive his
accrued salary and unreimbursed expenses through the date of
termination and payment for accrued but unused vacation.
Mr. Bramantis medical coverage at company expense
continues for the period specified above under any termination
event. Mr. Bramanti is entitled to payment for accrued but
unused vacation upon any termination event.
Edward
H. Ellis, Jr.
General. According to the terms of his
Employment Agreement effective as of March 1, 2007,
Mr. Ellis serves as Executive Vice President and Chief
Financial Officer of HCC. Mr. Elliss employment
agreement expires on December 31, 2009. He will receive a
salary of $550,000 in 2009. Mr. Ellis will be eligible to
receive bonus compensation under the 2008 Flexible Incentive
Plan. Mr. Ellis and his qualified beneficiaries are
entitled to extended medical coverage after termination of
Mr. Elliss employment at company expense. The
benefits are to last, in general, in the case of Mr. Ellis
and his spouse, until Mr. Ellis or his spouse becomes
eligible for Medicare, or, in the case of Mr. Elliss
qualified beneficiaries, until the date such person would have
ceased to be eligible for coverage under our group health plan
had Mr. Ellis remained an employee through the date such
coverage lapses. If the agreement is terminated, Mr. Ellis
has agreed to certain provisions relating to non-competition
(for two years post-termination), confidentiality, and
non-solicitation of customers and employees (for two years
post-termination).
Benefits upon the Occurrence of Certain Termination
Events. In the event Mr. Elliss
employment is terminated as a result of his death or disability,
he or his estate, as the case may be, will receive his accrued
salary and unreimbursed expenses through the date of
termination, a discounted lump sum cash payment equal to
Mr. Elliss base salary for the lesser of
18 months or the remainder of the term, a discounted lump
sum cash payment in lieu of benefits other than medical equal to
$1,350 times the lesser of 18 months or the remainder of
the term, consideration for a
29
bonus payment and continuing medical benefits as described
above. In the event Mr. Elliss employment is
terminated by HCC without Cause, by Mr. Ellis
for Good Reason or by Mr. Ellis after a
Change of Control, in each such case as set forth in
the agreement, Mr. Ellis will be entitled to receive his
accrued salary and unreimbursed expenses through the date of
termination, a discounted lump sum cash payment equal to the
amount of base salary that would have been payable for the
remainder of the term, a discounted lump sum cash payment in
lieu of benefits other than medical equal to $1,350 times the
number of months remaining in the term and continuing medical
benefits as described above. Mr. Ellis may terminate on a
Change of Control if within 12 months of a Change of
Control of HCC, there is a material change in the nature or
status of Mr. Elliss duties or responsibilities. In
the event Mr. Elliss employment is terminated for
Cause or by Mr. Ellis without Good
Reason, Mr. Ellis will be entitled to receive his
accrued salary and unreimbursed expenses through the date of
termination.
John
N. Molbeck, Jr.
General. According to the terms of his
Employment Agreement effective as of March 1, 2007,
Mr. Molbeck serves as President and Chief Operating Officer
of HCC. Mr. Molbecks employment agreement expires on
December 31, 2010. He will receive an annual salary of
$1,350,000 (consisting of a base salary of $1,000,000 and
deferred compensation of $350,000) during the term.
Mr. Molbeck will be eligible to receive bonus compensation
under the 2008 Flexible Incentive Plan. Mr. Molbeck and his
qualified beneficiaries are entitled to medical coverage at no
cost. Mr. Molbeck and his qualified beneficiaries are
entitled to extended medical coverage after termination of
Mr. Molbecks employment at company expense. The
benefits are to last until, in general, the later of the date
Mr. Molbeck or his spouse dies or, in the case of
Mr. Molbecks qualified beneficiaries, the date such
person would cease to be eligible for coverage under our group
health plan had Mr. Molbeck remained an employee through
the date such coverage lapses. Mr. Molbeck is also entitled
to certain other perquisites, including a car allowance,
reimbursement for estate planning expenses, supplementary term
life insurance of $1,000,000 at company expense and personal
travel on the corporate aircraft. The agreement provides that
upon termination for any reason, Mr. Molbeck will serve HCC
as a consultant for a period of six years and nine months and
receive an annual consulting fee of $256,200.
Mr. Molbecks right to receive the annual consulting
fees were vested at the inception of his employment agreement,
and such fees remain payable in the event of
Mr. Molbecks death or disability. We agreed to this
consulting arrangement during Mr. Molbecks previous
employment agreement with us and continued to be obligated by
it; therefore, we included the provision in his new employment
agreement. If the agreement is terminated, Mr. Molbeck has
agreed to certain provisions relating to non-competition (for
two years post-termination), confidentiality, and
non-solicitation of customers and employees (for two years
post-termination).
Benefits upon the Occurrence of Certain Termination
Events. In the event Mr. Molbecks
employment is terminated as a result of his death or disability,
he or his estate, as the case may be, will receive his accrued
salary and unreimbursed expenses through the date of
termination, a discounted lump sum cash payment equal to
Mr. Molbecks base salary and deferred compensation
for the lesser of 18 months or the remainder of the term, a
discounted amount equal to the consulting fees that would have
been paid to Mr. Molbeck had he retired on the expiration
date and provided the consulting services under the agreement,
continuing medical benefits as described above, consideration
for a bonus payment, and a discounted lump sum cash payment in
lieu of benefits other than medical equal to $4,650 times: in
the event of disability, the number of months remaining in the
term; and, in the event of death, the lesser of 18 months
or the number of months remaining in the term. In the event his
employment agreement is terminated by HCC without
Cause, by Mr. Molbeck for Good
Reason or by Mr. Molbeck after a Change of
Control, in each such case as set forth in the employment
agreement, Mr. Molbeck will be entitled to receive his
accrued salary and unreimbursed expenses through the date of
termination, a discounted lump sum cash payment equal to his
base salary and deferred compensation for the greater of
12 months or the remainder of the term, a discounted lump
sum cash payment in lieu of benefits other than medical equal to
$4,650 times the remaining number of months in the term,
continuing medical benefits as described above, consideration
for a bonus payment under our 2008 Flexible Incentive Plan if he
is a participant in that plan or a discretionary bonus if he is
not a participant, and, if applicable after a Change of Control,
reimbursement for any excise tax under Section 4999 of the
Internal Revenue Code. Mr. Molbeck may terminate his
employment for any reason within 180 days of a Change of
Control. In the event Mr. Molbecks employment is
terminated for Cause or by Mr. Molbeck without
Good Reason, Mr. Molbeck will be entitled to
receive his accrued salary and unreimbursed expenses through the
date of termination and continuing medical benefits.
30
Cory
L. Moulton
General. According to the terms of his Amended
and Restated Employment Agreement effective as of
September 1, 2008, Mr. Moulton serves as Executive
Vice President U.S. Property and Casualty
Operations of HCC. Mr. Moulton oversees our domestic
property and casualty operations. His employment agreement
expires on August 31, 2011. Mr. Moulton receives a
salary of $525,000 each year during the term of the agreement.
Mr. Moulton is eligible for a discretionary bonus to be
determined by our Compensation Committee, with a minimum agreed
bonus for 2008 of $400,000. If the agreement is terminated,
Mr. Moulton has agreed to certain provisions relating to
non-competition (for 12 months post-termination),
confidentiality, and non-solicitation of customers and employees
(for 24 months post-termination).
Benefits upon the Occurrence of Certain Termination
Events. In the event Mr. Moultons
employment is terminated as a result of his death or disability,
he or his estate, as the case may be, will receive his accrued
salary and unreimbursed expenses through the date of
termination, any bonus relating to a prior year that was unpaid
as of the date of death, and an amount equal to six months base
salary. In the event Mr. Moultons employment is
terminated by HCC without Cause, by Mr. Moulton
for Good Reason, by Mr. Moulton after a
Change of Control, or by Mr. Moulton for
Special Reason, in each such case as set forth in
the agreement, Mr. Moulton will be entitled to receive his
accrued salary and unreimbursed expenses through the date of
termination and a discounted lump sum cash payment equal to the
amount of base salary that would have been payable for the
remainder of the term. Mr. Moulton may terminate on a
Change of Control if within 12 months of a Change of
Control of HCC, there is a material change in the nature or
status of Mr. Moultons duties or responsibilities.
Mr. Moulton may terminate for Special Reason if he
continues in the position of Executive Vice
President U.S. Property and Casualty Operations
after December 31, 2009. In the event
Mr. Moultons employment is terminated for
Cause or by Mr. Moulton without Good
Reason, Mr. Moulton will be entitled to receive his
accrued salary and unreimbursed expenses through the date of
termination.
Craig
J. Kelbel
General. According to the terms of his
Employment Agreement effective as of March 1, 2007,
Mr. Kelbel acts as Executive Vice President of HCC and
President and Chief Executive Officer of HCC Life Insurance
Company. Mr. Kelbel oversees our domestic life, accident
and health operations. His employment agreement expires on
February 28, 2011. Mr. Kelbel receives a salary of
$612,000 each year during the term of the agreement. If
Mr. Kelbel is not a participant under our 2008 Flexible
Incentive Plan, he is eligible for a discretionary bonus to be
determined by our Compensation Committee. Mr. Kelbel and
his qualified beneficiaries are entitled to extended medical
coverage after termination of Mr. Kelbels employment
at company expense. The benefits are to last, in general, in the
case of Mr. Kelbel and his spouse, until Mr. Kelbel or
his spouse becomes eligible for Medicare, or, in the case of
Mr. Kelbels qualified beneficiaries, until the date
such person would have ceased to be eligible for coverage under
our group health plan had Mr. Kelbel remained an employee
through the date such coverage lapses. Mr. Kelbel is also
entitled to certain other perquisites, including country club
dues and a company-provided apartment. The agreement provides
that upon Mr. Kelbels retirement after
January 1, 2010 or upon termination for any reason other
than Cause, Mr. Kelbel will serve HCC as a
consultant for a period equal to the number of whole years after
January 1, 2002 in which Mr. Kelbel was a full-time
employee of HCC and will receive an annual consulting fee of
$75,000. If the employment agreement is terminated,
Mr. Kelbel has agreed to certain provisions relating to
non-competition (for two years post-termination),
confidentiality, and non-solicitation of customers and employees
(for two years post-termination).
Benefits upon the Occurrence of Certain Termination
Events. Mr. Kelbels rights upon
termination of his employment upon death or disability are
similar to those provided to Mr. Ellis, except that his
monthly cash payment in lieu of benefits other than medical is
$2,200. Mr. Kelbels rights upon termination of his
employment by HCC without Cause, by Mr. Kelbel
for Good Reason or by Mr. Kelbel after a
Change of Control, are similar to those provided to
Mr. Ellis, except that his monthly cash payment in lieu of
benefits other than medical is $2,200 and except that in
addition to other benefits, Mr. Kelbel is entitled to a
discounted lump sum cash payment in an amount equal to the total
consulting fees that would have been payable had Mr. Kelbel
retired on the expiration date of the agreement and provided
consulting services as set forth in the employment agreement.
31
Potential
Payments on Termination Following Certain Termination
Events
The following sets forth the incremental compensation that would
be payable by us to each of our Named Executive Officers in the
event of each Named Executive Officers termination of
employment with us under various scenarios, which we refer to as
termination events, including the Named Executive
Officers voluntary resignation, involuntary termination
for Cause, involuntary termination without
Cause, termination by the executive for Good
Reason, termination in connection with a Change of
Control, termination in the event of
Disability, termination in the event of death, and
termination in the event of retirement, where each of these
defined terms has the meaning ascribed to it in the respective
executives employment agreement. In accordance with
applicable SEC rules, the following discussion assumes:
|
|
|
|
|
that the termination event in question occurred on
December 31, 2008, the last business day of 2008; and
|
|
|
|
with respect to calculations based on our stock price, we used
$26.75, which was the reported closing price of our common stock
on December 31, 2008.
|
The analysis contained in this section does not consider or
include payments made to a Named Executive Officer with respect
to contracts, agreements, plans or arrangements to the extent
they do not discriminate in scope, terms or operation, in favor
of our executive officers and that are available generally to
all salaried employees, such as our 401(k) plan. The actual
amounts that would be paid upon a Named Executive Officers
termination of employment can only be determined at the time of
such executive officers termination. Due to the number of
factors that affect the nature and amount of any compensation or
benefits provided upon the termination events, any actual
amounts paid or distributed may be higher or lower than reported
below. Factors that could affect these amounts include the
timing during the year of any such event, our stock price at
such time, the
90-day
Treasury bill rate used to discount payments and the executive
officers age and service.
Each Named Executive Officer is party to an employment agreement
with us and to equity award agreements relating to options
and/or
restricted stock granted under our 2001 Flexible Incentive Plan,
our 2004 Flexible Incentive Plan
and/or our
2008 Flexible Incentive Plan. These agreements and plans may
provide that a Named Executive Officer is entitled to additional
consideration in the event of a termination event. All of the
Named Executive Officers employment agreements provide for
a cash payment in the event of termination without Cause or for
Good Reason. The terms of the employment agreements are
discussed more fully in the section immediately above.
Following is a discussion and related disclosure on potential
payments on a Change of Control for each of our Named Executive
Officers.
Each table below indicates the amount of compensation payable by
us to the applicable Named Executive Officer including: cash
severance, consulting fee payments, bonus payments, continuation
of health coverage, stock option awards, and excise tax
gross-up for
amounts due under Section 280G and 4999 of the Internal
Revenue Code
(Gross-Up),
upon different termination events.
Frank J. Bramanti. In addition to the amounts
listed below, Mr. Bramanti is entitled to all accrued
compensation and unreimbursed expenses through the date of
termination in the event of his termination.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Involuntary
|
|
|
Termination in
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Termination
|
|
|
Connection with
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
by HCC without
|
|
|
Change of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Involuntary
|
|
|
Cause or by
|
|
|
Control (without
|
|
|
Termination in
|
|
|
Termination in
|
|
|
Termination in
|
|
|
|
Voluntary
|
|
|
Termination
|
|
|
Executive for
|
|
|
Cause or for
|
|
|
the Event of
|
|
|
the Event of
|
|
|
the Event of
|
|
|
|
Resignation
|
|
|
for Cause
|
|
|
Good Reason
|
|
|
Good Reason)
|
|
|
Disability
|
|
|
Death
|
|
|
Retirement
|
|
Element
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
Cash Severance Payment(1)
|
|
|
|
|
|
|
|
|
|
|
4,312,092
|
|
|
|
4,312,092
|
|
|
|
3,027,594
|
|
|
|
3,027,594
|
|
|
|
|
|
Consulting Fee Payment(2)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bonus Payment(3)
|
|
|
1,500,000
|
|
|
|
1,500,000
|
|
|
|
1,500,000
|
|
|
|
1,500,000
|
|
|
|
1,500,000
|
|
|
|
1,500,000
|
|
|
|
1,500,000
|
|
Continued Health Coverage(4)
|
|
|
1,702,437
|
|
|
|
1,702,437
|
|
|
|
1,702,437
|
|
|
|
1,702,437
|
|
|
|
1,702,437
|
|
|
|
1,054,553
|
|
|
|
1,702,437
|
|
Stock Option Awards(5)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
3,202,437
|
|
|
|
3,202,437
|
|
|
|
7,514,529
|
|
|
|
7,514,529
|
|
|
|
6,230,031
|
|
|
|
5,582,147
|
|
|
|
3,202,437
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
32
|
|
|
(1) |
|
In the event of termination without Cause, termination for Good
Reason, or termination in connection with a Change of Control,
Mr. Bramanti will receive a discounted lump sum equal to
(i) base salary and deferred compensation for the remainder
of the employment agreement term, plus (ii) an amount equal
to $300,000 in lieu of the consulting fee that would have been
earned under the agreement had such termination not occurred,
plus (iii) an amount, in lieu of benefits other than
medical, equal to $1,583 times the number of months remaining in
the term, plus (iv) accrued but unused vacation. In the
event of termination due to Disability or death,
Mr. Bramanti or his estate, as applicable, will receive a
discounted lump sum in an aggregate amount equal to
(i) base salary and deferred compensation for the lesser of
18 months or the remainder of the term, plus (ii) an
amount, in lieu of benefits other than medical, equal to $1,583
times the lesser of 18 months or the number of months
remaining in the term, plus (iii) accrued but unused
vacation. In other termination events, Mr. Bramanti will
receive a cash payment for accrued but unused vacation. The
values included in the table above relating to cash severance
payments are the total amount, with no discount applied. |
|
(2) |
|
Mr. Bramanti will be retained as a consultant if he is
still employed by us on December 31, 2010 and if he ceases
to be an employee at that date other than as a result of
termination for Cause. |
|
(3) |
|
The amounts in this row represent an estimate of the potential
bonus payable to Mr. Bramanti based on the actual bonus
paid for 2008 and assuming the Compensation Committee would not
use its negative authority to reduce the bonus. |
|
(4) |
|
Mr. Bramanti is entitled to receive medical coverage for
life (or through his spouses life if longer) and for his
children through the age of 25 years in the event of
termination for any reason. The following assumptions have been
used to calculate the value of the expected benefits: coverage
is provided for health care premiums for Mr. Bramanti and
his spouse for life and health care premiums for his children up
to the age of 25; initial average annual cost of coverage
(grossed up for taxes) of $26,619 for two adults plus children,
$18,940 for one or no adult plus children or $9,755 for
individual coverage; and 4.67% annual health insurance premium
trend. |
|
(5) |
|
The acceleration of vesting of stock options, if any, is
governed under the terms of Mr. Bramantis various
option agreements governing the grants. In general, all option
grants will vest if Mr. Bramantis employment is
terminated in the event of Disability or death. The table above
shows no amount of intrinsic value for unvested options as of
December 31, 2008 that would have accelerated vesting upon
the termination event because the exercise price of all such
options is above HCCs closing stock price as of
December 31, 2008. |
Edward H. Ellis, Jr. In addition to the amounts
listed below, Mr. Ellis is entitled to all accrued
compensation, unreimbursed expenses and other benefits through
the date of termination in the event of his termination.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Involuntary
|
|
|
Termination in
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Termination by
|
|
|
Connection with
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
HCC without
|
|
|
Change of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Involuntary
|
|
|
Cause or by
|
|
|
Control (without
|
|
|
Termination in
|
|
|
Termination in
|
|
|
Termination in
|
|
|
|
Voluntary
|
|
|
Termination
|
|
|
Executive for
|
|
|
Cause or for
|
|
|
the Event of
|
|
|
the Event of
|
|
|
the Event of
|
|
|
|
Resignation
|
|
|
for Cause
|
|
|
Good Reason
|
|
|
Good Reason)
|
|
|
Disability
|
|
|
Death
|
|
|
Retirement
|
|
Element
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
Cash Severance Payment(1)
|
|
|
|
|
|
|
|
|
|
|
566,200
|
|
|
|
566,200
|
|
|
|
566,200
|
|
|
|
566,200
|
|
|
|
|
|
Bonus Payment(2)
|
|
|
400,000
|
|
|
|
400,000
|
|
|
|
400,000
|
|
|
|
400,000
|
|
|
|
400,000
|
|
|
|
400,000
|
|
|
|
400,000
|
|
Continued Health Coverage(3)
|
|
|
|
|
|
|
|
|
|
|
20,099
|
|
|
|
20,099
|
|
|
|
20,099
|
|
|
|
9,709
|
|
|
|
20,099
|
|
Stock Option Awards(4)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
400,000
|
|
|
|
400,000
|
|
|
|
986,299
|
|
|
|
986,299
|
|
|
|
986,299
|
|
|
|
975,909
|
|
|
|
420,099
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
In the event of termination without Cause, termination for Good
Reason, or termination in connection with a Change of Control,
Mr. Ellis will receive a discounted lump sum equal to
(i) base salary for the remainder of the employment
agreement term, plus (ii) an amount, in lieu of benefits
other than medical, equal to $1,350 times the number of months
remaining in the term. In the event of termination due to
Disability or death, Mr. Ellis or his estate, as
applicable, will receive a discounted lump sum equal to
(i) base salary for the lesser of 18 months or the
remaining term of the employment agreement, plus (ii) an
amount, in lieu of benefits other than medical, equal to $1,350
times the lesser of 18 months or the number of months
remaining in the term of the employment agreement. The values
included in the table above relating to cash severance payments
are the total amount, with no discount applied. |
33
|
|
|
(2) |
|
The amounts in this row represent an estimate of the potential
bonus payable to Mr. Ellis based on the actual bonus paid
for 2008 and assuming the Compensation Committee would not use
its negative authority to reduce the bonus. |
|
(3) |
|
In the event of termination of the agreement for any reason
other than voluntary termination, or termination for Cause,
Mr. Ellis and/or his qualified beneficiaries are entitled
to receive continued health coverage through COBRA at company
expense for as long as such coverage is available and thereafter
shall receive reimbursement for a comparable individual policy
or for coverage through an employer plan for a period commencing
on the date COBRA coverage ends and ending on, (i) in the
case of Mr. Ellis or his spouse, the dates he or she
becomes eligible for Medicare or, (ii) in the case of
Mr. Elliss qualified beneficiaries, the dates they
would have ceased to be eligible for coverage under our health
plans had Mr. Ellis remained an employee of the company.
The following assumptions have been used to calculate the value
of the expected benefits: coverage is provided for COBRA
premiums at retirement, initial average annual cost of coverage
of $12,059 for two adults or $6,211 for individual coverage, and
4.48% annual health insurance premium trend. Under COBRA, HCC
would pay premiums for 18 months after retirement or
36 months in the event that Mr. Ellis becomes disabled
during the
18-month
period. A 4.71% probability of disability was used. |
|
(4) |
|
The acceleration of vesting of stock options, if any, is
governed under the terms of Mr. Elliss various option
agreements governing the grants. In general, all option grants
will vest if Mr. Elliss employment is terminated in
the event of Disability or death. In addition, under certain of
Mr. Elliss option agreements, options will vest in
the event of involuntary termination without Cause, termination
for Good Reason, or termination in connection with a Change of
Control. The table above shows no amount of intrinsic value for
unvested options as of December 31, 2008 that would have
accelerated vesting upon the termination event because the
exercise price of all such options is above HCCs closing
stock price as of December 31, 2008. |
John N. Molbeck, Jr. In addition to the amounts
listed below, Mr. Molbeck is entitled to all accrued
compensation, unreimbursed expenses and other benefits through
the date of termination in the event of his termination.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Involuntary
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Termination
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
by HCC
|
|
|
Termination in
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
without
|
|
|
Connection with
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cause or
|
|
|
Change of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Involuntary
|
|
|
by Executive
|
|
|
Control (without
|
|
|
Termination in
|
|
|
Termination in
|
|
|
Termination in
|
|
|
|
Voluntary
|
|
|
Termination
|
|
|
for Good
|
|
|
Cause or for
|
|
|
the Event of
|
|
|
the Event of
|
|
|
the Event of
|
|
|
|
Resignation
|
|
|
for Cause
|
|
|
Reason
|
|
|
Good Reason)
|
|
|
Disability
|
|
|
Death
|
|
|
Retirement
|
|
Element
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)(1)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
Cash Severance Payment(2)
|
|
|
|
|
|
|
|
|
|
|
2,811,600
|
|
|
|
2,811,600
|
|
|
|
2,136,600
|
|
|
|
2,108,700
|
|
|
|
|
|
Consulting Fee Payment(3)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,729,350
|
|
|
|
1,729,350
|
|
|
|
|
|
Bonus Payment(4)
|
|
|
1,950,000
|
|
|
|
1,950,000
|
|
|
|
1,950,000
|
|
|
|
1,950,000
|
|
|
|
1,950,000
|
|
|
|
1,950,000
|
|
|
|
1,950,000
|
|
Continued Health Coverage(5)
|
|
|
924,053
|
|
|
|
924,053
|
|
|
|
924,053
|
|
|
|
924,053
|
|
|
|
924,053
|
|
|
|
540,187
|
|
|
|
924,053
|
|
Stock Option Awards(6)
|
|
|
|
|
|
|
|
|
|
|
34,200
|
|
|
|
34,200
|
|
|
|
34,200
|
|
|
|
34,200
|
|
|
|
|
|
280G Excise
Gross-Up(7)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,791,332
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
2,874,053
|
|
|
|
2,874,053
|
|
|
|
5,719,853
|
|
|
|
7,511,185
|
|
|
|
6,774,203
|
|
|
|
6,362,437
|
|
|
|
2,874,053
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Mr. Molbeck may terminate his employment within
180 days following a Change of Control for any reason (or
no reason). A showing of Good Reason is not needed to be
eligible to receive these benefits. |
|
(2) |
|
In the event of termination without Cause, for Good Reason or in
connection with a Change of Control, Mr. Molbeck will
receive a discounted lump sum equal to (i) base salary and
deferred compensation for the greater of 12 months or the
remainder of the employment term, plus (ii) an amount, in
lieu of benefits other than medical, equal to $4,650 times the
number of months remaining in the term. In the event of
termination due to Disability or death, Mr. Molbeck or his
estate, as applicable, will receive a discounted lump sum equal
to (i) base salary and deferred compensation for the lesser
of 18 months or the remaining term of the employment
agreement, plus (ii) an amount, in lieu of benefits other
than medical, equal to $4,650 times (x) in the event of
disability, the number of months remaining in the term of the
employment agreement, or (y) in the event of death, the
lesser of 18 months or the number of months remaining in
the term of the employment agreement. |
34
|
|
|
|
|
The values included in the table above relating to cash
severance payments are the total amount, with no discount
applied. |
|
(3) |
|
In the event of termination due to Disability or death,
Mr. Molbeck or his estate, as applicable, will receive a
discounted lump sum equal to the consulting fee that would have
been payable during the consulting period had Mr. Molbeck
retired on the expiration date of the employment agreement and
provided consulting services for the entire consulting period.
The value included in the table is equal to the total amount of
consulting fee payments over the consulting period, with no
discount applied. In addition, in the event of termination for
any other reason, although no payment will be due at
termination, we have agreed to retain Mr. Molbeck as a
consultant for six years and nine months after the date of such
termination. The values included in the table above relating to
consulting fee payments are the total amount, with no discount
applied. |
|
(4) |
|
The amounts in this row represent an estimate of the potential
bonus payable to Mr. Molbeck based on the actual bonus paid
for 2008 and assuming the Compensation Committee would not use
its negative authority to reduce the bonus. |
|
(5) |
|
In the event of termination of the agreement for any reason,
Mr. Molbeck and/or his qualified beneficiaries are entitled
to receive continued health coverage through COBRA at company
expense for as long as such coverage is available and thereafter
shall receive reimbursement for a comparable individual policy
or for coverage through an employer plan for a period commencing
on the date COBRA coverage ends and ending on, (i) in the
case of Mr. Molbeck or his spouse, the date he or she dies
or, (ii) in the case of Mr. Molbecks qualified
beneficiaries, the dates they would have ceased to be eligible
for coverage under our health plans had Mr. Molbeck
remained an employee of the company. The following assumptions
have been used to calculate the value of the expected benefits:
coverage is provided for health care premiums for
Mr. Molbeck and his spouse for life, initial average annual
cost of coverage (grossed up for taxes) of $18,940 for two
adults or $9,755 for individual coverage, and 4.67% annual
health insurance premium trend. |
|
(6) |
|
The acceleration of vesting of stock options, if any, is
governed under the terms of Mr. Molbecks various
option agreements governing the grants. All options granted will
vest in the event of involuntary termination without Cause,
termination for Good Reason, termination in connection with a
Change of Control, termination in the event of Disability, or
termination in the event of death. Amounts in the table above
represent the intrinsic value of unvested options as of
December 31, 2008 that have accelerated vesting upon the
termination event where the exercise prices of such options are
below HCCs closing price stock price on December 31,
2008. |
|
(7) |
|
Mr. Molbeck is eligible to receive a
Gross-Up
payment in the event he is subject to 280G excise tax. |
Cory L. Moulton. In addition to the amounts
listed below, Mr. Moulton is entitled to all accrued
compensation, unreimbursed expenses and other benefits through
the date of termination in the event of his termination.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Involuntary
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Termination by
|
|
|
Termination in
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
HCC without
|
|
|
Connection with
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cause or by
|
|
|
Change of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Involuntary
|
|
|
Executive for Good
|
|
|
Control (without
|
|
|
Termination in
|
|
|
Termination in
|
|
|
Termination in
|
|
|
|
Voluntary
|
|
|
Termination
|
|
|
Reason, including
|
|
|
Cause or for
|
|
|
the Event of
|
|
|
the Event of
|
|
|
the Event of
|
|
|
|
Resignation
|
|
|
for Cause
|
|
|
Special Reason
|
|
|
Good Reason)
|
|
|
Disability
|
|
|
Death
|
|
|
Retirement
|
|
Element
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
Cash Severance Payment(1)
|
|
|
|
|
|
|
|
|
|
|
1,400,000
|
|
|
|
1,400,000
|
|
|
|
262,500
|
|
|
|
262,500
|
|
|
|
|
|
Bonus Payment(2)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
400,000
|
|
|
|
400,000
|
|
|
|
|
|
Restricted Stock Awards(3)
|
|
|
|
|
|
|
|
|
|
|
584,675
|
|
|
|
584,675
|
|
|
|
584,675
|
|
|
|
584,675
|
|
|
|
|
|
Stock Option Awards(4)
|
|
|
|
|
|
|
|
|
|
|
478,200
|
|
|
|
478,200
|
|
|
|
478,200
|
|
|
|
478,200
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
2,462,875
|
|
|
|
2,462,875
|
|
|
|
1,725,375
|
|
|
|
1,725,375
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
In the event of termination without Cause, termination for Good
Reason (including the Special Reason that Mr. Moulton
remains employed in the position of Executive Vice
President U.S. Property and Casualty Operations
after December 31, 2009), or termination in connection with
a Change of Control, Mr. Moulton will receive a discounted
lump sum equal to base salary for the remainder of the
employment agreement term. In the event of termination due to
Disability or death, Mr. Moulton or his estate, as
applicable, will receive a discounted lump sum equal to base
salary for six months. The values included in the table above
relating to cash severance payments are the total amount, with
no discount applied. |
35
|
|
|
(2) |
|
In the event of termination due to Disability or death,
Mr. Moulton is entitled to any bonus that relates to a
prior year that is unpaid at the date of termination and to
consideration for a discretionary bonus payment with respect to
the year in which such termination occurs. Therefore, amounts in
this row represent an estimate of the potential bonus payable to
Mr. Moulton based on the actual bonus paid for 2008 and
assuming the Compensation Committee would use its discretion to
grant the same bonus in the event of termination due to
Disability or death. |
|
(3) |
|
The acceleration of vesting of restricted stock, if any, is
governed under the terms of the grant agreement for the
restricted stock. In general, all restricted stock will vest if
Mr. Moultons employment terminates due to Disability
or death or for any reason other than Cause (as
defined in the restricted stock grant agreement), or upon a
Change of Control (as defined in the 2008 Flexible Incentive
Plan) or other reorganization. Amounts in the table above
represent the intrinsic value of unvested restricted stock as of
December 31, 2008 that have accelerated vesting upon the
termination event. |
|
(4) |
|
The acceleration of vesting of stock options, if any, is
governed under the terms of Mr. Moultons various
option agreements governing the grants. In general, all option
grants will vest if Mr. Moultons employment is
terminated in the event of Disability or death. In addition,
under certain of Mr. Moultons option agreements,
options will vest in the event of involuntary termination
without Cause, termination for Good Reason, or termination in
connection with a Change of Control. Amounts in the table above
represent the intrinsic value of unvested options as of
December 31, 2008 that have accelerated vesting upon the
termination event where the exercise prices of such options are
below HCCs closing price stock price on December 31,
2008. |
Craig J. Kelbel. In addition to the amounts
listed below, Mr. Kelbel is entitled to all accrued
compensation, unreimbursed expenses, and other benefits through
the date of termination in the event of his termination.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Involuntary
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Termination
|
|
|
Termination in
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
by HCC
|
|
|
Connection with
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
without
|
|
|
Change of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Involuntary
|
|
|
Cause or by
|
|
|
Control (without
|
|
|
Termination in
|
|
|
Termination in
|
|
|
Termination in
|
|
|
|
Voluntary
|
|
|
Termination
|
|
|
Executive for
|
|
|
Cause or for
|
|
|
the Event of
|
|
|
the Event of
|
|
|
the Event of
|
|
|
|
Resignation
|
|
|
for Cause
|
|
|
Good Reason
|
|
|
Good Reason)
|
|
|
Disability
|
|
|
Death
|
|
|
Retirement
|
|
Element
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
Cash Severance Payment(1)
|
|
|
|
|
|
|
|
|
|
|
2,058,200
|
|
|
|
2,058,200
|
|
|
|
957,600
|
|
|
|
957,600
|
|
|
|
|
|
Consulting Fee Payment(2)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bonus Payment(3)
|
|
|
450,000
|
|
|
|
450,000
|
|
|
|
450,000
|
|
|
|
450,000
|
|
|
|
450,000
|
|
|
|
450,000
|
|
|
|
450,000
|
|
Continued Health Coverage(4)
|
|
|
|
|
|
|
|
|
|
|
79,548
|
|
|
|
79,548
|
|
|
|
79,548
|
|
|
|
|
|
|
|
79,548
|
|
Stock Option Awards(5)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
450,000
|
|
|
|
450,000
|
|
|
|
2,587,748
|
|
|
|
2,587,748
|
|
|
|
1,487,148
|
|
|
|
1,407,600
|
|
|
|
529,548
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
In the event of termination without Cause, termination for Good
Reason, or termination in connection with a Change of Control,
Mr. Kelbel will receive a discounted lump sum equal to
(i) base salary for the remainder of the employment
agreement term; plus (ii) $675,000 in lieu of the
consulting fee that would have been earned under the agreement
had such termination not occurred; plus (iii) an amount, in
lieu of benefits other than medical, equal to $2,200 times the
number of months remaining in the term. In the event of
termination due to Disability or death, Mr. Kelbel or his
estate, as applicable, will receive a discounted lump sum equal
to (i) base salary for the lesser of 18 months or the
remaining term of the employment agreement, plus
(ii) $675,000 in lieu of the consulting fee that would have
been earned under the agreement had such termination not
occurred; plus (iii) an amount, in lieu of benefits other
than medical, equal to $2,200 times the lesser of 18 months
or the number of months remaining in the term of the employment
agreement. The values included in the table above relating to
cash severance payments are the total amount, with no discount
applied. |
|
(2) |
|
Mr. Kelbel will be retained as a consultant if he is still
employed by us on January 1, 2010 and if he ceases to be an
employee after that date other than as a result of termination
for Cause. |
|
(3) |
|
The amounts in this row represent an estimate of the potential
bonus payable to Mr. Kelbel based on the actual bonus paid
for 2008 and assuming the Compensation Committee would not use
its negative authority to reduce the bonus. |
36
|
|
|
(4) |
|
In the event of termination of the agreement for any reason
other than voluntary termination by Mr. Kelbel or
termination for Cause, Mr. Kelbel and/or his qualified
beneficiaries are entitled to receive continued health coverage
through COBRA at company expense for as long as such coverage is
available and thereafter shall receive reimbursement for a
comparable individual policy or for coverage through an employer
plan for a period commencing on the date COBRA coverage ends and
ending on, (i) in the case of Mr. Kelbel or his
spouse, the dates he or she becomes eligible for Medicare
coverage or, (ii) in the case of Mr. Kelbels
qualified beneficiaries, the dates they would have ceased to be
eligible for coverage under our health plans had Mr. Kelbel
remained an employee of the company. The following assumptions
have been used to calculate the value of the expected benefits:
coverage is provided for continuation of health insurance until
Mr. Kelbel is eligible for Medicare at age 65, initial
average annual cost of coverage of $6,211, and 4.48% annual
health insurance premium trend. |
|
(5) |
|
The acceleration of vesting of stock options, if any, is
governed under the terms of Mr. Kelbels various
option agreements governing the grants. In general, all option
grants will vest if Mr. Kelbels employment is
terminated in the event of Disability or death. The table above
shows no amount of intrinsic value for unvested options as of
December 31, 2008 that would have accelerated vesting upon
the termination event because the exercise price of all such
options is above HCCs closing stock price as of
December 31, 2008. |
2008
Compensation of Directors
The table below summarizes the compensation paid by us to our
non-employee directors. We also reimburse our directors for
travel, lodging and related expenses incurred in attending Board
or Committee meetings and for directors education programs
and seminars.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nonqualified
|
|
|
|
|
|
|
|
|
|
Fees Earned or
|
|
|
|
|
|
|
|
|
Deferred
|
|
|
|
|
|
|
|
|
|
Paid in Cash
|
|
|
Stock Award
|
|
|
Option Award
|
|
|
Compensation
|
|
|
Total
|
|
|
|
|
Name
|
|
($)
|
|
|
($)(1)
|
|
|
($)(2)
|
|
|
($)(3)
|
|
|
($)
|
|
|
|
|
|
Patrick B. Collins(4)
|
|
|
127,000
|
|
|
|
80,000
|
|
|
|
|
|
|
|
|
|
|
|
207,000
|
|
|
|
|
|
J. Robert Dickerson(5)
|
|
|
184,718
|
|
|
|
80,000
|
|
|
|
|
|
|
|
|
|
|
|
264,718
|
|
|
|
|
|
Walter M. Duer(6)
|
|
|
119,000
|
|
|
|
80,000
|
|
|
|
49,452
|
|
|
|
49
|
|
|
|
248,501
|
|
|
|
|
|
James C. Flagg, Ph.D.(7)
|
|
|
139,000
|
|
|
|
80,000
|
|
|
|
|
|
|
|
|
|
|
|
219,000
|
|
|
|
|
|
Allan W. Fulkerson(8)
|
|
|
146,000
|
|
|
|
80,000
|
|
|
|
|
|
|
|
|
|
|
|
226,000
|
|
|
|
|
|
Thomas M. Hamilton(9)
|
|
|
17,560
|
|
|
|
38,356
|
|
|
|
|
|
|
|
|
|
|
|
55,916
|
|
|
|
|
|
James E. Oesterreicher(10)
|
|
|
108,361
|
|
|
|
80,000
|
|
|
|
|
|
|
|
|
|
|
|
188,361
|
|
|
|
|
|
Michael A. F. Roberts(11)
|
|
|
152,000
|
|
|
|
80,000
|
|
|
|
|
|
|
|
|
|
|
|
232,000
|
|
|
|
|
|
Robert A. Rosholt(12)
|
|
|
38,614
|
|
|
|
58,301
|
|
|
|
|
|
|
|
|
|
|
|
96,915
|
|
|
|
|
|
Christopher J. B. Williams(13)
|
|
|
138,902
|
|
|
|
80,000
|
|
|
|
|
|
|
|
|
|
|
|
218,902
|
|
|
|
|
|
Scott W. Wise(14)
|
|
|
59,640
|
|
|
|
80,000
|
|
|
|
|
|
|
|
|
|
|
|
139,640
|
|
|
|
|
|
|
|
|
(1) |
|
On May 14, 2008, each Independent Director serving at that
time received a grant under our 2008 Flexible Incentive Plan of
$80,000 in our common stock, which was 3,330 shares based
on the closing price of our stock on the grant date of $24.02
per share. Mr. Rosholt received a grant of $58,301 (pro
rata portion of the $80,000 annual grant) in our common stock
when he joined our Board on August 20, 2008, which was
2,427 shares based on the closing price of our stock on the
grant date of $24.02. Mr. Hamilton received a grant of
$38,356 (pro rata portion of the $80,000 annual grant) in our
common stock when he joined our Board on November 20, 2008,
which was 1,988 shares, all of which Mr. Hamilton
elected to defer, based on the closing price of our stock on the
grant date of $19.29. All shares were fully vested on the grant
date. |
|
(2) |
|
Stock options that were granted to our non-employee directors in
prior years vest over periods of one to five years. This column
includes the expense we recognized in our 2008 consolidated
income statements under Statement of Financial Accounting
Standards No. 123(R), Share-Based Payment. For a
discussion of the assumptions used in calculating the fair value
of our stock-based compensation, refer to Note 1,
General Information and Significant Accounting and Reporting
Policies Stock-Based Compensation, and
Note 11, Stock-Based Compensation, in the Notes to
Consolidated Financial Statements contained in our Annual Report
on Form 10-K
for the year ended December 31, 2008. |
37
|
|
|
(3) |
|
In 2008, Mr. Duer deferred $59,507 of fees earned under our
Nonqualified Deferred Compensation Plan for Non-Employee
Directors, and Mr. Hamilton deferred $48,892 of cash fees
and common stock. Mr. Duer had $2,603 in total earnings on
amounts deferred under the Plan, of which $49 is considered
above-market earnings under SEC regulations. Earnings on
deferred compensation are deemed above-market only if the rate
exceeds 120% of the applicable federal long-term rate, with
compounding. |
|
(4) |
|
At December 31, 2008, Mr. Collins had 31,250 options
outstanding, of which 31,250 were exercisable. |
|
(5) |
|
At December 31, 2008, Mr. Dickerson had 31,250 options
outstanding, of which 31,250 were exercisable. |
|
(6) |
|
At December 31, 2008, Mr. Duer had 66,750 options
outstanding of which 59,250 were exercisable. |
|
(7) |
|
At December 31, 2008, Dr. Flagg had 31,250 options
outstanding, of which 31,250 were exercisable. |
|
(8) |
|
At December 31, 2008, Mr. Fulkerson had 31,250 options
outstanding, of which 31,250 were exercisable. |
|
(9) |
|
At December 31, 2008, Mr. Hamilton had no options
outstanding. |
|
(10) |
|
At December 31, 2008, Mr. Oesterreicher had no options
outstanding. |
|
(11) |
|
At December 31, 2008, Mr. Roberts had 31,250 options
outstanding, of which 31,250 were exercisable. |
|
(12) |
|
At December 31, 2008, Mr. Rosholt had no options
outstanding. |
|
(13) |
|
At December 31, 2008, Mr. Williams had no options
outstanding. |
|
(14) |
|
At December 31, 2008, Mr. Wise had no options
outstanding. |
Retainers. In 2008, we compensated our
non-employee directors by a combination of retainers, meeting
fees and a block grant of fully-vested common stock. Board
members received retainers for serving on our Board as set forth
in the following table:
|
|
|
|
|
|
|
Retainer
|
|
Position
|
|
($)
|
|
|
Board Member
|
|
|
75,000
|
|
Chairman
|
|
|
75,000
|
|
Audit Committee Chairman
|
|
|
25,000
|
|
Compensation Committee Chairman
|
|
|
15,000
|
|
Nominating and Corporate Governance Committee Chairman
|
|
|
15,000
|
|
Executive Risk Oversight Committee Chairman
|
|
|
15,000
|
|
Investment and Finance Committee Chairman
|
|
|
15,000
|
|
Meeting Fees. Our non-employee directors
received meeting fees as set forth in the following table:
|
|
|
|
|
|
|
|
|
|
|
In-person
|
|
Teleconference
|
|
|
Meeting ($)
|
|
Meeting ($)
|
|
Board of Directors
|
|
|
5,000
|
|
|
|
1,000
|
|
Committee Meeting
|
|
|
2,000
|
|
|
|
1,000
|
|
Equity Compensation. Our non-employee
directors also receive a block grant of common stock in the
amount of the number of shares determined by dividing $80,000 by
the closing price of our common stock on the date of the Annual
Meeting of Shareholders, which is generally held in May of each
year. If a director joins our Board on a date other than the
Annual Meeting date, he receives stock worth a pro rata portion
of $80,000 for the partial year. In 2008, Mr. Rosholt
joined our Board on August 20, 2008 and received shares
worth $58,301, and Mr. Hamilton joined our board on
November 20, 2008 and received shares worth $38,356.
Deferred Compensation. Our non-employee
directors are also entitled to defer all or portion of their
cash consideration under the HCC Insurance Holdings, Inc.
Nonqualified Deferred Compensation Plan for Non-Employee
Directors. All of our non-employee directors are eligible to
participate under the plan. Participants may elect to defer up
to 100% of the cash or stock compensation they are to receive
from us by means of a deferral election made in accordance with
the terms of the plan. The cash compensation credited to a
participants account will accrue earnings, which shall
compound monthly, at the participants election at any of
the following rates: the prime rate (4.875% for 2008), the rate
of return on HCC common stock (-4.85% for 2008), or the rate of
return on the S&P 500 (-37.00% for 2008). Deferred stock
compensation will be deemed invested in HCC common stock, with
dividends reinvested. Payment of the participants account
balance will be paid in the time period set forth in
38
the deferral election, or if no such time is elected, then in a
lump sum after separation from service. The plan is administered
by our Compensation Committee. No separate trust or fund shall
be created, and all benefits payable under the plan will be paid
from HCCs general assets.
Stock Ownership Requirements. The Board has
established a minimum stock ownership requirement for Directors
of $300,000 in HCC common stock. Directors are to have achieved
the required ownership within three years of the later of
May 10, 2007, the adoption date of the policy, or the date
they join the Board. The Board may grant waivers to these
ownership requirements. At December 31, 2008,
Messrs. Collins, Dickerson, Fulkerson and Roberts had met
these requirements.
Certain Stock Options. Although it is no
longer our practice to grant stock options to our directors,
certain of our directors still own options to purchase our
common stock. In general, under their terms, these options would
expire 60 days after a directors retirement from our
Board. However, with respect to the directors
(Messrs. Collins, Dickerson, Fulkerson and Roberts) who
will be retiring from our Board effective as of our annual
meeting of shareholders on May 21, 2009, the Compensation
Committee has elected to extend the exercisability of the
options held by such directors until such time as the options
expire in accordance with their respective terms.
39
PROPOSAL NUMBER
2 RATIFICATION OF OUR AUDITOR FOR 2009
Our Audit Committee has selected PricewaterhouseCoopers LLP to
serve as our independent registered public accounting firm to
examine our consolidated financial statements for the year
ending December 31, 2009. While the Audit Committee is
responsible for the appointment, compensation, retention,
termination and oversight of the independent auditor, we are
requesting, as a matter of good corporate governance, that the
shareholders ratify the appointment of PricewaterhouseCoopers
LLP as our principal independent registered public accounting
firm. If the shareholders fail to ratify the selection, the
Audit Committee will reconsider whether to retain
PricewaterhouseCoopers LLP and may retain that firm or another
without re-submitting the matter to our shareholders. Even if
the appointment is ratified, the Audit Committee may, in its
discretion, direct the appointment of a different independent
registered public accounting firm at any time during the year if
it determines that such change would be in our best interests
and in the best interests of our shareholders.
PricewaterhouseCoopers LLPs representatives are expected
to be present at the Annual Meeting and will have an opportunity
to make a statement, if they so desire, as well as to respond to
appropriate questions asked by our shareholders.
Our Board of Directors recommends that our shareholders vote
FOR ratification of the selection of
PricewaterhouseCoopers LLP as our independent registered public
accounting firm.
Fees Paid
to PricewaterhouseCoopers LLP
Audit
Fees
During the years ended December 31, 2008 and 2007, the
aggregate fees billed by PricewaterhouseCoopers LLP for the
audit of our consolidated financial statements and statutory
financial statements of our insurance company subsidiaries,
actuarial certifications, review of our interim financial
statements, review of our systems of internal control over
financial reporting and other professional services related to
SEC registration statements were $3,800,000 and $4,200,000,
respectively.
Audit-Related
Fees
During the years ended December 31, 2008 and 2007, the
aggregate fees for certain
agreed-upon
procedures performed by PricewaterhouseCoopers LLP that related
to the performance of the audit or review of our financial
statements but are not reportable as Audit Fees were $20,000 and
$117,000, respectively.
Tax
Fees
During the years ended December 31, 2008 and 2007, the
aggregate fees billed by PricewaterhouseCoopers LLP for tax
compliance, tax advice and tax planning services were $452,000
and $347,000, respectively. Such fees related to professional
services for preparation of selected domestic and foreign tax
returns of HCC and our subsidiaries, as well as advice with
respect to domestic and international tax issues related to tax
return compliance and the acquisition, disposition or
reorganization of subsidiaries.
All
Other Fees
During the years ended December 31, 2008 and 2007, the
aggregate fees billed for services rendered by
PricewaterhouseCoopers LLP not reportable as Audit Fees,
Audit-Related Fees or Tax Fees were $17,000 and $31,000,
respectively. Such fees related to licenses for electronic
databases and training courses for our employees.
The services provided by PricewaterhouseCoopers LLP described in
Audit-Related Fees, Tax Fees and
All Other Fees above, were approved by the Audit
Committee according to
Rule 2-01(c)(7)(i)(C)
of
Regulation S-X.
The Audit Committee has determined the rendering of the
above-mentioned non-audit services by PricewaterhouseCoopers LLP
was compatible with maintaining our independent registered
public accounting firms independence.
Audit
Committee Pre-Approval Policies and Procedures
The Audit Committees policy provides that our independent
registered public accounting firm may provide only those
services pre-approved by the Audit Committee or its designated
subcommittee. The Audit Committee is required to pre-approve all
auditing services and non-audit services that are provided to
us. If the Audit Committee
40
approves an audit service within the scope of the engagement of
the independent registered public accounting firm, such audit
service will be deemed to have been pre-approved.
Committee pre-approval is not required under the policies of the
Audit Committee for non-audit services provided by the
independent registered public accounting firm if the aggregate
amount of all such non-audit services provided to HCC
constitutes not more than the 5% of the total amount of fees
paid by us to the independent registered public accounting firm
during the fiscal year in which such non-audit services are
provided, such non-audit services were not recognized by us at
the time of the independent registered public accounting
firms engagement to be non-audit services, and such
non-audit services are promptly brought to the attention of the
Committee and approved by the Committee prior to the completion
of the audit.
The Audit Committee may delegate to one or more members of the
Audit Committee the authority to grant pre-approval of non-audit
services. However, the decision of any member to whom such
authority is delegated to pre-approve non-audit services shall
be presented to the full Audit Committee for its approval at its
next scheduled meeting. As of the record date, there had been no
such delegation.
41
REPORT OF
THE AUDIT COMMITTEE
The Audit Committee is composed of three Independent Directors
and acts under a written charter adopted by the Board of
Directors. The Audit Committee consists of Mr. Duer,
Dr. Flagg (Chairman) and Mr. Rosholt.
Mr. Williams serves as an ex officio member of the Audit
Committee.
The Audit Committee is responsible for overseeing HCCs
financial reporting process on behalf of the Board of Directors.
The Audit Committee has the sole responsibility for the
appointment and retention of HCCs independent registered
public accounting firm and the approval of all audit and other
engagement fees. The Audit Committee meets periodically with
management, the internal auditors and the independent registered
public accounting firm regarding accounting policies and
procedures, audit results and internal accounting controls. The
internal auditors and the independent registered public
accounting firm have free access to the Audit Committee, without
managements presence, to discuss the scope and results of
their audit work.
HCCs management is primarily responsible for its financial
statements and the quality and integrity of the reporting
process, including establishing and maintaining systems of
internal control over financial reporting and assessing the
effectiveness of those controls. The independent registered
public accounting firm PricewaterhouseCoopers LLP is responsible
for auditing those financial statements and for expressing an
opinion on the conformity of the consolidated financial
statements with accounting principles generally accepted in the
United States of America and on whether HCC maintained effective
internal control over financial reporting.
In fulfilling its oversight responsibilities, the Audit
Committee has reviewed and discussed the audited consolidated
financial statements for the year ended December 31, 2008
and managements report of the effectiveness of HCCs
system of internal control over financial reporting with
HCCs management and representatives of the independent
registered public accounting firm. The Audit Committee discussed
with the independent registered public accounting firm the
matters required to be discussed by Statement on Auditing
Standards No. 61, Communication with Audit
Committees, as amended, as adopted by the Public Company
Accounting Oversight Board in Rule 3200T. In addition, the
Audit Committee discussed with the independent registered public
accounting firm its independence from HCC and HCCs
management, and has received the written disclosures and the
letter from the independent registered public account firm
required by applicable requirements of the Public Company
Accounting Oversight Board regarding the independent registered
public accounting firms communications with the Audit
Committee concerning independence. The Audit Committee has
considered the compatibility of non-audit services, primarily
tax and merger and acquisition activities.
PricewaterhouseCoopers LLP audited the financial records of HCC
and its subsidiaries for the year ended December 31, 2008
and has served as HCCs independent registered public
accounting firm since 1987. Representatives of
PricewaterhouseCoopers LLP are expected to be present at the
Annual Meeting of Shareholders and will have an opportunity to
make a statement if they so desire and will be available to
respond to appropriate questions.
In reliance on its review of the audited consolidated financial
statements, the review of the report of management on the
effectiveness of HCCs internal control over financial
reporting, the discussions referred to above and the receipt of
the written disclosures referred to above, the Audit Committee
has recommended to the Board of Directors that the audited
consolidated financial statements be included in HCCs
Annual Report on
Form 10-K
for the year ended December 31, 2008, for filing with the
SEC.
Submitted by the Audit Committee:
James C. Flagg, Ph.D., Chairman
Walter M. Duer
Robert A. Rosholt
42
OTHER
BUSINESS
The Board of Directors has no knowledge of any other matter to
be submitted at the Annual Meeting of Shareholders. If any other
matter shall properly come before the annual meeting, the
persons named in this Proxy Statement will have discretionary
authority to vote the shares thereby represented in accordance
with their best judgment.
INCORPORATION
BY REFERENCE
Notwithstanding anything to the contrary set forth in any of our
previous filings under the Securities Act of 1933, as amended,
or the Exchange Act, that might incorporate future filings
including this Proxy Statement, in whole or in part, the report
of the Compensation Committee and the report of the Audit
Committee included in this Proxy Statement shall not be
incorporated by reference to any such filings.
SHAREHOLDER
PROPOSALS
Any shareholder proposal intended to be presented for
consideration at the 2010 Annual Meeting of Shareholders and to
be included in our Proxy Statement for such meeting must be in
proper form and received by our Secretary at HCCs
principal executive offices by the close of business on
December 16, 2009. We recommend that a proponent submit any
proposal by Certified Mail, Return Receipt Requested and that
all proposals should be sent to the attention of the Secretary.
Shareholder proposals submitted outside of the procedure set
forth above, which will not be included in our Proxy Statement,
including nominations for directors, must be mailed to James L.
Simmons, Secretary, HCC Insurance Holdings, Inc., 13403
Northwest Freeway, Houston, Texas
77040-6094,
and must be received by the Secretary no earlier than
January 30, 2010 and no later than March 2, 2010. If
the proposal is received after that date, our proxy for the 2010
Annual Meeting may confer discretionary authority to vote on
such matter without any discussion of such matter in the proxy
statement for the 2010 Annual Meeting. With respect to the
nomination of directors, refer to Nominating and Corporate
Governance Committee Shareholder
Recommendations, which requirements will also apply.
Nothing in this section shall be deemed to require us to
|
|
|
|
|
permit presentation of a shareholder proposal; or
|
|
|
|
include in our proxy materials relating to our 2009 annual
meeting any shareholder proposal
|
that does not meet all of the requirements for such presentation
or inclusion contained in our Bylaws
and/or state
and federal securities laws and regulations in effect at that
time.
We entered into negotiations with the shareholder proponents
that presented proposals at our 2007 and 2008 Annual Meetings.
As a result of these negotiations, we amended our equal
employment opportunity policies as requested by the shareholder
proponents.
Form 10-K
We will furnish without charge to each person whose proxy is
being solicited, upon request of any such person, a copy of our
Annual Report on
Form 10-K
for the year ended December 31, 2008, as filed with the
SEC, including the consolidated financial statements and
schedules thereto, but not the exhibits. Requests for copies of
such report should be directed to Barney White, Investor
Relations, HCC Insurance Holdings, Inc., 13403 Northwest
Freeway, Houston, Texas
77040-6094.
Copies of any exhibit to the
Form 10-K
will be forwarded upon receipt of a written request addressed to
Mr. White.
Important
Notice Regarding Internet Availability of Proxy Materials for
the 2009 Annual Meeting to be held on May 21,
2009
Our proxy material relating to our 2009 Annual Meeting
(notice, proxy statement, proxy and 2008 Annual Report)
will be available at Investor Relations on our
website at www.hcc.com.
For the date, time and location of the 2009 Annual Meeting and
an identification of the matters to be voted upon at the 2009
Annual Meeting, please see the Notice of Annual Meeting of
Shareholders. For the Boards recommendations
regarding those matters, please refer to
Proposal Number 1 Election of
Directors and
43
Proposal Number 2 Ratification of Our
Auditors for 2009. For information on how to obtain
directions to be able to attend the meeting and vote in person,
please contact Barney White, Investor Relations, HCC Insurance
Holdings, Inc., 13403 Northwest Freeway, Houston, Texas
77040-6094.
EACH SHAREHOLDER WHO DOES NOT EXPECT TO ATTEND THE ANNUAL
MEETING OF SHAREHOLDERS IN PERSON IS URGED TO EXECUTE THE PROXY
CARD AND RETURN IT PROMPTLY IN THE ENCLOSED ENVELOPE OR SUBMIT
THE PROXY BY TELEPHONE OR USING THE INTERNET. NO POSTAGE IS
NECESSARY IF MAILED IN THE UNITED STATES.
By Order of the Board of Directors,
James L. Simmons,
Vice President and Secretary
April 13, 2009
44